Skip to main content
Open Access · CC BY 4.0
For Authors

Submissions

Login or Register to make a submission.

Publishing fee (APC): EUR 200, or EUR 150 for ASTES members, taxes excluded, charged only after acceptance. Fees and how to pay »

Templates and forms

Download the forms, complete and sign them, and upload them with your manuscript. Each form names the sections it covers; the corresponding author may sign on behalf of all authors where the form says so.

At submission

All four are required. Upload them in the file step of the submission, each under its own file type: Anonymised Manuscript, Title Page, Cover Letter, and Author Declaration Form.

Journal policies (PDF)

Printable versions of the policies on this site.

Author Guidelines

The Albanian Journal of Trauma and Emergency Surgery (AJTES) welcomes submissions from clinicians, researchers, and allied health professionals worldwide. The journal publishes in English and follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), and the World Association of Medical Editors (WAME).

Please read these instructions in full before submitting. Manuscripts that do not comply may be returned to the authors before peer review. Submissions are made through the journal’s online system; a free author account is required.

On this page: Before you submit · Article types and limits · Files to prepare · Manuscript format · Structure by article type · Scientific style and units · Statistics and data reporting · Figures and tables · References · Ethics requirements · Reporting guidelines · Authorship · Mandatory declarations · AI tools · Preprints · Second-language publication · What happens after you submit · Charges · After publication · Contact

1. Before you submit

Confirm that your manuscript meets each of the following. These are the points on which most returned submissions fail.

  • The work is original, has not been published elsewhere (except as an abstract, thesis, conference presentation, or preprint, each of which must be disclosed at submission, or an acceptable secondary publication under §15a), and is not under consideration by another journal.
  • The topic falls within the journal’s scope: trauma, emergency, acute care, and critical care surgery and medicine, and closely related clinical, translational, and health-services research. Manuscripts outside this scope are declined without review, regardless of quality.
  • All named authors meet the authorship criteria and have approved the submitted version.
  • Required ethical approvals and consents were obtained before the research began, and the corresponding statements appear in the manuscript.
  • The manuscript is written in clear, professional English. Manuscripts whose English is not of a standard that allows the science to be assessed may be returned to the authors before peer review, with a recommendation to seek language editing. This is not a judgement on the research: authors writing in a second language are encouraged to use a professional language-editing service or a fluent colleague before submitting. The journal does not provide language editing, and use of such a service confers no advantage in the editorial decision.
  • Reporting follows the relevant reporting guideline for the study design.

Back to top ↑

2. Article types and limits

Word counts exclude the title page, abstract, references, tables, and figure legends. The limits below are indicative; a well-justified manuscript that exceeds them may still be considered, but authors should explain why in the cover letter.

Article type Words Abstract References Tables / figures
Research Article 3,000–5,000 250–350, structured 20–60 up to 6
Review Article up to 4,500 up to 350, unstructured up to 150 up to 6
Case Reports up to 2,500 up to 250 up to 20 up to 4
Short Report up to 2,000 up to 250 up to 20 up to 3
Commentaries up to 2,000 up to 250 up to 40 up to 2
Perspective Article up to 2,500 up to 250 up to 30 up to 2
Opinion Article up to 2,000 up to 250 up to 20 up to 2
Letter to the Editor up to 1,000 none up to 10 up to 1
News and Updates up to 1,500 none up to 10 up to 2
Congress Proceedings 350 per abstract the item is itself an abstract up to 5 up to 1
Conference Paper as for the corresponding article type (Research Article or Review)

The Article Processing Charge is set out in §17.

Full definitions of each type, including what the editors look for and whether it is externally peer reviewed, are given on the journal’s Article Types page. Where that page and the table above differ, the table above applies.

Back to top ↑

3. Files to prepare

Upload the following as separate files. Because AJTES operates double-anonymised (double-blind) peer review, keeping identifying information out of the main manuscript is essential. When you upload each file, the submission system asks what kind of file it is: choose the type shown in brackets below. Where the journal provides a template or form, it is listed under Templates and forms at the top of this page.

  1. Cover letter [Cover Letter] — use the Cover Letter Template (Templates and forms). State the article type, why the work suits AJTES, that it is original and not under consideration elsewhere, and disclose any related publications, preprints, or prior submissions, and any use of generative AI (§14). Suggested reviewers may be proposed here (with affiliation and email); the editors are not bound by such suggestions and will exclude anyone with an apparent conflict.
  2. Title page (unblinded) [Title Page] — use the Title Page Template (Templates and forms); see §5.1.
  3. Main manuscript (blinded) [Anonymized Manuscript] — use the Anonymized Manuscript Template (Templates and forms). No author names, affiliations, acknowledgments, funding details, or institution names in the text, headers, or file properties. Refer to your own prior work in the third person (“Smith et al. reported…”), never as “our previous study”. Remove identifying metadata from the Word file (File → Info → Inspect Document).
  4. Figures [Figure] — optional at first submission. You may either place each figure in the manuscript next to where it is first cited, or upload each one as a separate file of type Figure. Once the manuscript is accepted, every figure is needed as its own high-resolution file (see §8).
  5. Tables [Anonymized Manuscript if inside the manuscript, otherwise Table] — editable text, either at the end of the manuscript or in a separate file.
  6. Ethical documentation [Other] — ethics committee approval letter and/or consent forms, where applicable. These are seen by editors only and are not published.
  7. Reporting checklist [Other] — the completed checklist for your study design (see §11), with the page number of each item indicated.
  8. Signed declaration forms [Author Declaration Form] — two forms, both under Templates and forms:
    • the Author Declaration Form (Parts A–F), completed and signed by the corresponding author on behalf of all authors: A, authorship and the author list; B, each author’s contributions (CRediT roles); C, acknowledgments and writing assistance; D, originality and warranties; E, the publishing license (CC BY 4.0); F, final confirmation; with a declaration on the use of artificial intelligence. It replaces the former Authorship Contributions Form, Conflicts of Interest Statement, Acknowledgments Form and separate License Agreement;
    • an ICMJE Disclosure Form for every author (mandatory), each saved as Surname_GivenName_ICMJE.pdf.
  9. Supplementary material [Other] — optional; clearly labeled and cited in the text as “Supplementary File 1”, “Supplementary File 2”, and so on.
  10. License — no separate step at acceptance. The publishing license is granted in Part E of the Author Declaration Form signed at submission; its full terms are on the License Agreement page. It takes effect only on acceptance and confers no rights on the journal if the manuscript is rejected or withdrawn.

Back to top ↑

4. Manuscript format

  • File format: Microsoft Word (.docx). PDF is not accepted for the main manuscript.
  • Font: Times New Roman 12 pt; line spacing 1.5; margins 2–2.5 cm.
  • Continuous line numbers and page numbers throughout — this is required so reviewers can cite precise locations. If your Word (.docx) manuscript is uploaded without continuous line numbering, the submission system switches it on automatically; nothing else in the file is changed. Page numbers you must add yourself (Insert → Page Number).
  • Left-aligned text, no automatic hyphenation, no columns.
  • Headings limited to three levels; do not number headings beyond the standard structure.

Back to top ↑

5. Structure by article type

5.1 Title page (submitted separately, unblinded)

  • Full article title. Titles should be specific and informative; declarative titles that state the conclusion are discouraged. Avoid abbreviations.
  • A short running title of up to 50 characters (including spaces). Enter this only where the submission form asks for it — do not place it in the journal’s subtitle field, as it will then be appended to the published title.
  • Full names of all authors, in the intended published order, with institutional affiliations (department, institution, city, country) linked by superscript numerals.
  • Corresponding author: full postal address, email, and telephone.
  • ORCID iD. An ORCID iD is expected for the corresponding author and strongly encouraged for all co-authors. ORCID distinguishes you from researchers with similar names, ensures your work is correctly attributed to you across databases, and is used by Crossref and indexing services. Registration is free at orcid.org and takes a few minutes.
  • Word count of the main text, number of tables and figures.
  • Acknowledgments, funding, and conflict-of-interest statements (these belong here, not in the blinded manuscript).

5.2 Research Articles

Follow the IMRaD structure: Introduction, Materials and Methods, Results, Discussion, followed by Conclusions, Declarations, and References.

  • Structured abstract (250–350 words) in IMRaD form, under the headings Introduction, Methods, Results, Conclusions (the submission form has one box for each). The abstract must contain actual data — key numerical results with measures of variability and significance — not a promise that results “will be discussed”. Abstracts are the part of your paper most widely read and indexed.
  • Keywords: 3–6 terms, preferably from MeSH.
  • Introduction: establish what is known, identify the specific gap, and state the aim or hypothesis in the final paragraph. Keep to the literature necessary to frame the question.
  • Materials and Methods: sufficient detail for replication — study design, setting and dates, eligibility criteria, sampling, interventions, outcome definitions, data sources, handling of missing data, and statistical methods with software and version. State the ethics approval and consent here.
  • Results: report findings in a logical sequence without interpretation. Do not duplicate table data in the text; highlight the important findings and refer to the tables.
  • Discussion: begin with the principal findings, compare them with the existing literature, state the clinical implications, and give an explicit, honest limitations paragraph. Do not restate the results at length.
  • Conclusions: supported strictly by the data presented. Avoid overstatement and recommendations that the study cannot support.

5.3 Case Reports

Title page; abstract; Keywords; Introduction; Case Presentation (including a clinical timeline); Discussion; Conclusions; Patient Consent Statement; Declarations; References. Follow the CARE guideline and provide a clinical timeline. A case report is publishable when it teaches something: a rare presentation, a diagnostic pitfall, an innovative technique, an unexpected complication, or a clear management lesson. Reports of common conditions managed conventionally are declined. Written informed consent for publication is mandatory and must be stated explicitly.

5.4 Review Articles

Narrative reviews: Abstract; Introduction; thematic sections; Conclusions. State how the literature was identified even in a narrative review — the databases searched, the period covered, and the selection criteria applied.

A systematic review must also follow PRISMA, reproduce the full search strategy for at least one database, and specify eligibility criteria, risk-of-bias assessment, and synthesis methods. Prospective registration (for example in PROSPERO) is expected, with the registration number given.

5.5 Other types

Short Reports follow the Research Article structure in condensed form, with an unstructured abstract of up to 250 words. Letters to the Editor, Commentaries, Perspectives, and Opinion Articles are continuous prose without a structured abstract, but must still be evidence-based and referenced.

Back to top ↑

6. Scientific style and units

  • Use SI units. Where clinical convention differs, give conventional units with SI in parentheses.
  • Define every abbreviation at first use in the abstract and again at first use in the main text. Avoid non-standard abbreviations; never use them in the title.
  • Use generic drug names; a proprietary name may follow in parentheses at first mention, with manufacturer and location.
  • Identify equipment and devices by manufacturer and location at first mention.
  • Report patient descriptors (age, sex, ethnicity) only where relevant, and describe how they were determined.
  • Use “patients” or “participants” rather than depersonalizing terms such as “cases” or “subjects” where possible.
  • Write in the past tense for methods and results; use the active voice where it improves clarity.

Back to top ↑

7. Statistics and data reporting

  • Name every statistical test and state the software and version used.
  • Report effect sizes with 95% confidence intervals, not p-values alone. Give exact p-values (e.g. p = 0.03) rather than thresholds; use p < 0.001 only below that value.
  • State how the sample size was determined; where a power calculation was performed, give its assumptions.
  • Describe how missing data were handled and report the number of participants at each stage.
  • Distinguish clearly between pre-specified and post-hoc/exploratory analyses.
  • For diagnostic accuracy studies, report sensitivity, specificity, and predictive values with confidence intervals.
  • Do not describe non-significant differences as “trends towards significance”.

Back to top ↑

8. Figures and tables

How to supply figures. At first submission, figures may be placed in the manuscript next to where they are first cited, or uploaded as separate files of type Figure, whichever is easier. Uploading them separately is optional at this stage. After acceptance, every figure is required as its own high-resolution file, named by its number (Fig1.tif, Fig2.jpg, …).

  • Every figure and table must be cited in the text in numerical order (Fig. 1) or (Table 1), and carry a self-explanatory caption or legend.
  • Legends go in the manuscript, in a “Figure legends” section after the references, not inside the image itself. Begin each with “Fig. 1” and identify every symbol, arrow, and abbreviation used. Label figure parts with lowercase letters (a, b, c).
  • Resolution and format: minimum 300 dpi for photographs and clinical images, 600 dpi for images combining photographs with text, and 1,200 dpi for line art (graphs, diagrams); TIFF, PNG, or high-quality JPEG, or vector EPS/PDF for charts. Do not use low-resolution screenshots or images copied from slides.
  • Color and lettering: submit color images in RGB; color is free. Use a sans-serif font (Arial or Helvetica) for lettering, about 8–12 pt at final size and consistent across figures.
  • Accessibility: do not rely on color alone to convey a difference; add patterns, symbols, or direct labels so the figure can be read in greyscale and by readers with color-vision deficiency.
  • Tables must be editable text, not images, created with Word’s table tool. Define all abbreviations in a footnote.
  • Clinical photographs must not permit patient identification. Where identification is possible, written consent for publication is mandatory; black bars over the eyes are not sufficient anonymization.
  • Radiological images should be cropped to remove patient identifiers and burnt-in metadata.
  • Any figure, table, or instrument reproduced or adapted from another source requires written permission from the copyright holder, and the source must be cited in the legend. Authors are responsible for obtaining permission.
  • Image manipulation beyond uniform adjustment of brightness and contrast is not permitted; grouping or splicing of images must be disclosed and made visually explicit.

Back to top ↑

9. References

References follow the Vancouver style, in the format of the US National Library of Medicine (Citing Medicine) as recommended by the ICMJE. It is the style most widely used by biomedical journals.

  • In-text citation: number references consecutively in the order in which they are first cited, using Arabic numerals in square brackets: “…to reduce mortality [1].”, “[2,3]”, “[4–7]”. A reference cited again keeps its original number. References cited only in tables or figure legends are numbered in sequence from where the table or figure is first cited in the text.
  • Reference list: numbered in citation order (not alphabetically), at the end of the manuscript. List up to six authors; with seven or more, list the first six followed by “et al.”.
  • Journal titles are abbreviated as in the NLM Catalog (for example, J Trauma Acute Care Surg); if a journal is not listed, use the ISSN List of Title Word Abbreviations or give the title in full.
  • Include the DOI wherever one exists. Accurate DOIs let Crossref link every reference to its source and count citations to your work.
  • Cite primary, peer-reviewed sources. Avoid citing conference abstracts (except the abstract from which the submitted work derives, which must be cited), and do not cite retracted articles other than to discuss the retraction (check the Retraction Watch Database).
  • Personal communications and unpublished data are cited in the text only, with written permission, and do not appear in the reference list.
  • Reference-management software (EndNote, Zotero, Mendeley) with the Vancouver or NLM output style is strongly recommended. Check every reference against its source: references generated by AI tools are a known source of fabricated citations (§14).

Journal article:
Moore EE, Cogbill TH, Jurkovich GJ, Shackford SR, Malangoni MA, Champion HR. Organ injury scaling: spleen and liver (1994 revision). J Trauma. 1995;38(3):323-4. doi:10.1097/00005373-199503000-00001

Journal article, more than six authors:
Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):98. doi:10.1186/s13054-019-2347-3

Book chapter:
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Online resource:
World Health Organization. Guidelines for essential trauma care [Internet]. Geneva: World Health Organization; 2004 [cited 2026 Oct 1]. Available from: https://www.who.int/publications/i/item/guidelines-for-essential-trauma-care

More examples for every type of source are given in the National Library of Medicine’s Samples of Formatted References.

Back to top ↑

10. Ethics requirements

  • Human research. Studies involving human participants, their tissue, or their identifiable data require approval by a research ethics committee or institutional review board. The approving body, reference number, and date are given in full on the title page; in the blinded manuscript, the committee name may be replaced by “[withheld for review]” (see §13). Research must comply with the World Medical Association Declaration of Helsinki.
  • Informed consent. State that informed consent was obtained from participants, or that the committee waived it and on what grounds. For case reports and any identifiable material, written consent for publication is required without exception.
  • Retrospective studies are not exempt: ethical approval or a documented waiver must still be reported.
  • Clinical trials must be prospectively registered in a registry of the WHO International Clinical Trials Registry Platform or ClinicalTrials.gov, as required by the ICMJE; give the registry name and number in the abstract. Retrospectively registered trials will normally be declined.
  • Animal research must comply with institutional and national regulations and follow the ARRIVE guidelines, and the approving body must be named.
  • Vulnerable populations (children, unconscious or critically ill patients, prisoners) require explicit description of how consent or assent was obtained.

Manuscripts lacking the required ethical statements are returned to the authors and are not sent for review until the information is supplied.

Back to top ↑

11. Reporting guidelines

Submit the completed checklist for your study design, indicating the page on which each item appears. Every checklist is available free from the EQUATOR Network; the links below go directly to each one.

If your study is a… Use Also required
Randomised controlled trial CONSORT Prospective trial registration number
Non-randomized interventional study TREND Registration where applicable
Observational study (cohort, case-control, cross-sectional) STROBE —
Systematic review or meta-analysis PRISMA Full search strategy; PROSPERO registration
Case report CARE Written consent for publication
Prediction model or risk score (development or validation) TRIPOD (TRIPOD+AI for machine-learning models) —
Diagnostic accuracy study STARD —
Animal research ARRIVE Institutional animal ethics approval
Quality improvement study SQUIRE —
Qualitative research SRQR or COREQ —
Economic evaluation CHEERS —

Reporting sex and gender (SAGER). Injury patterns, presentation, and outcomes in trauma and acute care differ by sex and by gender, and studies that do not report them cannot be applied confidently to either group. AJTES therefore follows the Sex and Gender Equity in Research (SAGER) guidelines of the European Association of Science Editors. Authors should:

  • use sex for biological attributes and gender for social and cultural identity, and not use the two interchangeably;
  • report the sex and, where relevant, the gender of participants in the Methods, and the numbers in each group in the Results;
  • report outcome data disaggregated by sex where sample size allows, and say so explicitly where it does not;
  • state in the Methods whether sex or gender was considered in the study design, and in the Discussion what the findings mean for generalisability;
  • state the sex of animals, cells, or tissue in laboratory work, and justify studying only one sex.

Where a study covers only one sex, or where sex and gender are not applicable to the research question, say so and explain why rather than leaving it unaddressed. Editors and reviewers consider SAGER compliance during assessment and may ask for clarification.

Back to top ↑

12. Authorship and contributorship

Authorship is limited to those who meet all four ICMJE criteria: substantial contribution to conception or design, or to acquisition, analysis, or interpretation of data; drafting or critically revising the work; final approval of the version to be published; and agreement to be accountable for all aspects of the work.

  • Acquisition of funding, general supervision, or provision of materials alone does not justify authorship. Such contributions belong in the Acknowledgments, with the named person’s permission.
  • Gift, guest, and ghost authorship are forms of misconduct and are grounds for rejection or retraction.
  • A contributorship statement describing what each author did is required for the article types marked * in §13 (the CRediT contributor roles are encouraged).
  • Changes to the author list after submission — addition, removal, or reordering — require a written request to the Editorial Office signed by all authors, including the person added or removed, with the reason. Changes after acceptance are made only in exceptional circumstances.
  • Group authorship must identify the individuals who take responsibility for the content.
  • The corresponding author is responsible for communication, for ensuring all co-authors have approved the manuscript, and for responding to post-publication queries.

Back to top ↑

13. Mandatory declarations

Declarations are split between two files to keep peer review anonymous and are combined in the published article. In the blinded manuscript, before the references: ethical approval (committee name replaced by “[withheld for review]”), consent, data and code availability, and use of AI. On the title page: conflict of interest, funding, acknowledgments, and author contributions, with the full name and reference of the ethics committee. Items marked * are required in Research Articles, Short Reports, Case Reports, Reviews, and Conference Papers.

  • Ethical approval — committee name, reference number, date; or an explicit statement of why approval was not required.
  • Consent to participate — obtained, waived by the committee (with grounds), or not applicable.
  • Consent for publication — required for case reports and for any image or detail that could identify a patient: state that written consent for publication was obtained, or “Not applicable”.
  • Conflict of interest — all financial and non-financial competing interests for every author, covering the 36 months before submission: employment, consultancies, honoraria, paid expert testimony, patents, grants, stock, and personal or institutional relationships. If none, state “The authors declare no competing interests.” Each author also completes the ICMJE Disclosure Form (§3).
  • Funding — all sources with grant numbers, and a statement of the funder’s role in the study; or “This research received no specific grant from any funding agency.”
  • Data and code availability* — where the underlying data (and any analysis code) are held and how they may be accessed, including any restrictions and the reason for them.
  • Author contributions* — see §12.
  • Acknowledgments — non-author contributors, with their permission.
  • Use of AI* — a statement is required whether or not AI was used; see §14 and the Artificial Intelligence Policy.

Back to top ↑

14. Use of artificial intelligence

  • AI tools cannot be listed as authors. They cannot take responsibility for the work, and authorship requires accountability.
  • Generative AI must not be used to produce the substantive scientific content of a manuscript — its interpretation, argument, or conclusions. Permitted supporting uses (language, grammar, readability, translation, and literature searching, provided every source is independently verified) must be disclosed in the declarations, naming the tool, version, date, and purpose. Every research article must state whether AI was used. See the Artificial Intelligence Policy for the full list of permitted and prohibited uses.
  • AI must not be used to generate, alter, or fabricate data, images, or references.
  • The authors remain fully responsible for the accuracy and integrity of all content, including anything produced with AI assistance. Fabricated citations introduced by AI tools are treated as a serious integrity failure.
  • Reviewers and editors may not upload manuscripts to any generative AI system or external service, as this breaches confidentiality.

Back to top ↑

15. Preprints

AJTES considers manuscripts previously posted to a recognized preprint server. Disclose the server, identifier, and DOI at submission. On publication, authors should update the preprint record with a link to the published Version of Record. Posting a preprint does not affect editorial assessment.

Back to top ↑

15a. Publication in a second language

An article published in AJTES may be republished in another language, and AJTES will consider a paper already published in a language other than English, provided the ICMJE conditions for acceptable secondary publication are met. This matters for a journal serving a region where clinically important work is often first reported in Albanian or another national language, and where restricting it to a single language would keep it from the readership that needs it.

Secondary publication is acceptable where all of the following hold:

  • the editors of both journals have agreed to it, and the editor of the second journal has seen the primary version;
  • the secondary version faithfully reflects the data and interpretation of the primary version, and is not an expanded or altered analysis;
  • an interval agreed by both editors has elapsed, unless both agree that immediate publication is justified on public-health grounds;
  • the secondary version is aimed at a different readership, and an abbreviated version may be sufficient;
  • the secondary version carries a footnote on its title page telling readers that the article was first published elsewhere, and citing the primary article in full;
  • permission from the holder of the rights in the primary version has been obtained in writing.

Secondary publication that meets these conditions is not duplicate publication and is not treated as misconduct. Republishing without disclosure and without the agreement of both editors is handled under Research Integrity.

Back to top ↑

16. What happens after you submit

  1. Editorial screening (normally within two weeks): scope, compliance with these instructions, ethical documentation, and language. Manuscripts may be declined at this stage without external review.
  2. Similarity screening using iThenticate (Crossref Similarity Check), before the manuscript is sent to reviewers. Reports are assessed manually with references, quotations, and standard methodological phrasing excluded; overlap above the thresholds published on the Peer Review Process page is reviewed by the handling editor. You may be asked to revise, or the manuscript may be handled under the journal’s Research Integrity policy.
  3. Double-anonymized peer review (for externally reviewed article types; see Article Types) by at least two independent experts, with a statistical reviewer where appropriate. This typically takes four to eight weeks.
  4. Decision: Accept, Minor Revision, Major Revision, or Reject.
  5. Revision: submit a revised manuscript with all changes marked, plus a point-by-point response to every reviewer comment. Time spent on revision is not counted in the journal’s stated review times. Revised manuscripts may return to the original reviewers.
  6. Acceptance, production, and proofs — see §18.

Authors may appeal a decision by writing to the Editorial Office within 30 days of the decision, with a point-by-point, evidence-based justification. Appeals are acknowledged within five working days. The appeal is assessed by an editor who took no part in the original decision and who has authority to overturn it; where the original decision was taken by the Editor-in-Chief, the appeal is assigned by the Chair of the Editorial Board to a Deputy Editor who is not employed by the Editor-in-Chief’s institution, or to an external editor from outside AJTES and ASTES. Additional reviewers may be consulted. You will receive a reasoned written outcome, normally within eight weeks. One appeal per manuscript is considered.

Back to top ↑

17. Article Processing Charges

  • EUR 200 per accepted article; EUR 150 for members of the Albanian Society for Trauma and Emergency Surgery (ASTES). Taxes are excluded: VAT or other taxes are added where applicable. An invoice is issued for every charge. To pay, use the bank details under Fees and Payment.
  • There is no submission fee. The charge applies only after acceptance, and payment is requested at that stage.
  • Editorial decisions are made solely on scholarly merit. The ability to pay plays no part in acceptance, and the editors handling a manuscript are not informed of payment status while the decision is pending.
  • Withdrawal is free at any stage before acceptance (written request signed by all authors, stating the reason). After acceptance, it is possible only for justified reasons, with the Editor-in-Chief’s approval, and a fee of up to 30% of the APC may be charged for costs already incurred. Published articles are not withdrawn; they are corrected or retracted in line with COPE guidance.

Back to top ↑

18. Production, proofs, and after publication

  • Accepted manuscripts are copy-edited and typeset. The corresponding author receives proofs for approval; only typographical and factual corrections are possible at this stage, and any material change needs the editor’s approval.
  • Articles are published open access under CC BY 4.0, and authors retain copyright.

Versions of your article

The journal uses standard version terminology, and it matters for what you may deposit where:

  • Submitted Manuscript (preprint) — the version before peer review. May be posted to a preprint server at any time; disclose it at submission.
  • Author Accepted Manuscript (AAM) — the peer-reviewed, accepted version before copy-editing and typesetting. May be deposited in an institutional or subject repository immediately on acceptance, without embargo.
  • Version of Record (VoR) — the final published article as it appears in the journal, carrying the DOI, the license, and the publication date. This is the definitive, citable version. It may also be deposited immediately, without embargo, under CC BY 4.0.
  • Versions of the Version of Record — where a published article is amended in a way that cannot bear on how it is read or credited, a new version of the VoR is published. Every earlier version stays permanently accessible at its own address, and the article page lists the full history. This route is never used for changes to data, results, conclusions, the author list, or any funding, competing-interest, ethics, consent, or data-availability statement; those are handled under Research Integrity.

Where a correction, expression of concern, or retraction is issued, the notice is linked to the Version of Record, which remains available; the record is corrected, not quietly rewritten.

Crossref services and metadata

  • DOI registration. Every article receives a Crossref DOI (prefix 10.32391) on publication, so it remains citable and resolvable independently of this website.
  • Metadata deposit. Article metadata — titles, authors, abstracts, license, and ORCID iDs that authors have verified through ORCID — is deposited with Crossref and is available for harvesting by indexing services.
  • Similarity Check. The journal participates in Crossref Similarity Check, using iThenticate to screen every submission (see §16).
  • OAI-PMH. The journal exposes an OAI-PMH interface so that DOAJ, aggregators, and library discovery systems can harvest its metadata.
  • Corrections: notify the Editorial Office promptly of any error. Depending on severity, the journal publishes a correction, an expression of concern, or a retraction, following COPE guidance; an amendment that does not affect how the article is read or credited is published instead as a new version. Whether an amendment is minor is decided by the editors, not by the authors. Corrections are linked to the original article, which remains available — the published record is corrected, not quietly rewritten.

Back to top ↑

19. Contact

Pre-submission inquiries, questions about these instructions, invoices and payments, appeals, authorship changes, and post-publication concerns should be addressed to:

AJTES Editorial Office
Street “Lord Bajron” No. 40, 1000 Tirana, Albania
Email: editorial@journal.astes.org.al

Back to top ↑

Version 1.1, approved by the Editorial Board on 20 October 2026. Reviewed at least every two years.

Submission Preparation Checklist

Before submitting, confirm that your manuscript meets every point below. Submissions that do not comply may be returned without review. Full detail for each item is given in the Instructions for Authors.

General

  • The manuscript is original, has not been published (other than as a disclosed abstract, thesis, presentation, preprint, or acceptable secondary publication), and is not under consideration elsewhere.
  • The subject falls within the journal’s scope: trauma, emergency, acute care, or critical care is the substantive subject of the work.
  • It is written in clear, professional English and follows the Instructions for Authors.
  • All authors meet the ICMJE authorship criteria and have approved this version.
  • The manuscript is within the word, reference, and table/figure limits for the chosen article type (limits are indicative; justify any excess in the cover letter).

Files

  • Anonymised manuscript, using the Anonymised Manuscript Template.
  • Title page, using the Title Page Template.
  • Cover letter, using the Cover Letter Template.
  • Author Declaration Form, completed and signed.

The templates are on the For Authors page, under Templates and forms.

Manuscript

  • Continuous line numbers and page numbers throughout.
  • Abstract within the limit for the article type (250–350 words, structured, for Research Articles) and 3–6 keywords, preferably MeSH terms.
  • References in the Vancouver style: numbered in square brackets in order of first citation, NLM journal abbreviations, up to six authors then “et al.”, with DOIs where available.
  • Mandatory declarations included: in the blinded manuscript, ethical approval (committee withheld for review), consent to participate and for publication, data and code availability, and an AI-use statement (required whether or not AI was used); on the title page, conflict of interest, funding, acknowledgements, and author contributions.
  • Clinical trials: prospective registration number provided.
  • Preprint status is disclosed if applicable.
  • Written permission obtained for any figure, table, or instrument reproduced from another source.

Policies

  • I agree to publication under the CC BY 4.0 licence, with copyright retained by the authors.
  • I acknowledge the Article Processing Charge applicable to my article type, payable only after acceptance (taxes excluded; VAT or other taxes added where applicable). There is no submission fee; the reduced rate applies to ASTES members only.

Version 1.1, approved by the Editorial Board on 20 October 2026. Reviewed at least every two years.

Article Types

Select a type to see its scope, length limits, and required structure.

Review Article (Narrative)

Definition and Scope

Narrative Review Articles are comprehensive, evidence-informed scholarly publications that critically examine, interpret, and synthesize existing scientific knowledge on topics of significant clinical, surgical, educational, or scientific relevance.

These articles aim to provide an authoritative overview of current evidence, clarify established concepts, critically discuss controversies, identify knowledge gaps, and highlight implications for clinical practice and future research.

Unlike Systematic Reviews, Narrative Reviews do not require a fully systematic, reproducible literature search, predefined study eligibility criteria, a formal risk-of-bias assessment, or quantitative meta-analysis.

However, Narrative Reviews must demonstrate scientific accuracy, critical reasoning, appropriate referencing, balanced interpretation, and transparency regarding the approach used to identify and select relevant literature.

AJTES welcomes Narrative Reviews addressing trauma care, emergency surgery, acute care surgery, critical care, perioperative management, surgical techniques, patient safety, and related medical disciplines.

Manuscripts should provide meaningful scientific or educational insights rather than merely summarize previously published findings.

Suitable Topics

Narrative Reviews may address:

  • Current concepts and advances in trauma and emergency surgery.
  • Diagnostic and therapeutic strategies for acute surgical conditions.
  • Surgical anatomy and clinically relevant anatomical variations.
  • Operative techniques and evolving surgical approaches.
  • Management of traumatic injuries and postoperative complications.
  • Advances in diagnostic imaging and interventional procedures.
  • Perioperative and critical care management.
  • Patient safety, surgical outcomes, and complication prevention.
  • Clinical controversies and emerging treatment strategies.
  • Trauma systems and organization of emergency surgical care.
  • Surgical education, professional training, and simulation.
  • Emerging technologies and innovations in acute care surgery.

Scientific and Methodological Requirements

Narrative Reviews must have a clearly defined scope, scientific rationale, and educational or clinical objective.

Authors should critically evaluate and integrate relevant evidence from reliable scientific sources, including original research studies, systematic reviews, clinical practice guidelines, consensus statements, and other appropriate publications.

The manuscript should:

  • Clearly explain the clinical or scientific importance of the topic.
  • State the objectives and scope of the review.
  • Describe the approach used to identify and select relevant literature.
  • Prioritize relevant, reliable, and appropriately current scientific evidence.
  • Distinguish established findings from emerging hypotheses and expert interpretations.
  • Critically discuss conflicting findings and areas of uncertainty.
  • Evaluate the methodological strengths and limitations of the cited evidence.
  • Avoid selective citation and unsupported generalizations.
  • Identify important knowledge gaps and future research priorities.
  • Provide balanced, evidence-informed conclusions.

A formal systematic search is not mandatory. Nevertheless, authors are encouraged to describe the databases searched, approximate search period, principal search terms, and approach to literature selection when appropriate.

The literature selection approach must not be represented as exhaustive or systematic unless the corresponding methodology has actually been performed.

Manuscript Structure

Narrative Reviews should follow a flexible, logically organized structure with appropriate thematic headings.

1. Title Page

A separate title page containing the manuscript title, full author names, institutional affiliations, corresponding author information, and required declarations.

The title should clearly identify the article as a Narrative Review when appropriate.

2. Unstructured Abstract

A concise summary of the topic, rationale, review objectives, principal themes, and clinical or scientific implications.

3. Keywords

Three to six relevant keywords, preferably aligned with Medical Subject Headings (MeSH).

4. Introduction

The clinical or scientific background, significance of the topic, relevant knowledge gaps, and objectives of the review.

5. Literature Search Approach (Recommended)

A concise description of how relevant literature was identified, including information sources, search concepts, approximate date range, and selection approach, where applicable.

This section is encouraged to improve transparency but does not convert a Narrative Review into a Systematic Review.

6. Main Review / Thematic Discussion

A structured and critical synthesis of the available evidence, organized into relevant thematic sections.

Depending on the topic, these sections may address epidemiology, pathophysiology, anatomical considerations, diagnosis, treatment, surgical management, complications, outcomes, or preventive strategies.

7. Clinical or Surgical Implications

A focused discussion of how current evidence applies to clinical decision-making, surgical practice, patient safety, and healthcare outcomes.

8. Limitations and Evidence Gaps

A critical discussion of key limitations in the available literature, unresolved controversies, evidence uncertainty, and limitations of the narrative review approach.

9. Future Directions

Identification of priorities for future clinical research, surgical innovation, methodological development, or healthcare improvement, where appropriate.

10. Conclusions

A concise, evidence-informed synthesis of the principal findings and their implications for clinical practice or future research.

11. Declarations

Author contributions, conflicts of interest, funding, data availability where applicable, and other required disclosures.

12. References

Relevant scientific publications accurately cited and formatted according to AJTES referencing requirements.

Abstract Requirements

An unstructured abstract of up to 350 words is required.

The abstract should briefly communicate:

  • The clinical or scientific background and significance of the topic.
  • The principal objectives and scope of the review.
  • The main themes or evidence-based observations.
  • Important controversies or knowledge gaps, where relevant.
  • The principal clinical, surgical, educational, or scientific implications.
  • The main conclusions.

The abstract must be presented as continuous prose without mandatory section headings.

It must accurately reflect the manuscript and must not imply that a formal systematic review or meta-analysis was conducted unless such methodology was actually performed.

Literature Search and Evidence Selection

Although a comprehensive systematic search is not mandatory, transparency in literature identification and selection is strongly encouraged.

Authors should describe, where applicable:

  • The bibliographic databases or information sources consulted.
  • The principal search terms or concepts.
  • The approximate period covered by the literature search.
  • The general criteria used to prioritize relevant publications.
  • The use of original research, systematic reviews, guidelines, or consensus statements.
  • Any relevant limitations of the literature selection approach.

Authors must not selectively cite studies solely because they support a preferred interpretation.

Where conflicting evidence exists, relevant alternative findings should be acknowledged and critically discussed.

References should support the principal scientific arguments and reflect an appropriate balance of foundational and recent literature.

Reporting Guidelines and Quality Assessment

There is no universally mandated reporting checklist specifically developed for all Narrative Reviews.

Authors are encouraged to follow the principles of the Scale for the Assessment of Narrative Review Articles (SANRA) as a framework for improving manuscript quality.

The SANRA framework addresses six key aspects:

  1. Justification of the article's importance.
  2. Clear statement of the review's objectives.
  3. Description of the literature search.
  4. Appropriate referencing.
  5. Scientific reasoning and presentation of evidence.
  6. Appropriate presentation of relevant outcome data.

SANRA is a quality-assessment instrument and should not be represented as a mandatory reporting guideline equivalent to PRISMA 2020.

The PRISMA checklist and flow diagram are not required for conventional Narrative Reviews.

If a manuscript uses a formal systematic review methodology, including predefined eligibility criteria, reproducible searching, systematic study selection, and critical appraisal, authors should consider submitting it under the Systematic Review category.

Protocol Registration

Protocol registration is not ordinarily required for conventional Narrative Reviews.

Authors may use a prespecified review plan or publicly available protocol to improve transparency.

However, prospective registration in registries such as PROSPERO is intended for eligible systematic review protocols and is not a routine requirement for Narrative Reviews.

A Narrative Review should not be described as a registered Systematic Review unless the relevant systematic methodology and registration requirements have been fulfilled.

Ethical Considerations and Research Integrity

Narrative Reviews based exclusively on published, publicly available, non-identifiable scientific literature do not ordinarily require new ethics committee approval.

However, authors must comply with applicable ethical, legal, institutional, and publication requirements if the manuscript includes unpublished confidential material, identifiable patient information, or original patient-level data.

All submissions must comply with AJTES policies on originality, authorship, plagiarism, duplicate publication, conflicts of interest, funding disclosure, scientific integrity, and responsible use of artificial intelligence.

Previously published images, tables, and illustrations must be appropriately cited, and reproduction or adaptation permission must be obtained when required.

Tables, Figures, and Illustrations

Tables and figures should enhance the scientific and educational value of the review.

Suitable visual materials may include:

  • Anatomical or surgical illustrations.
  • Diagnostic and treatment algorithms.
  • Comparative summaries of clinical evidence.
  • Classification systems.
  • Imaging findings and procedural illustrations.
  • Tables summarizing major studies, interventions, or clinical recommendations.

All tables and figures must be numbered consecutively, cited in the manuscript, and accompanied by informative titles or legends.

Images must comply with applicable copyright, licensing, confidentiality, and patient consent requirements.

Highlights and Running Title

Highlights: Authors must provide 3–5 concise statements summarizing the principal evidence-based findings, clinical implications, or educational messages. Each highlight must not exceed 85 characters, including spaces.

Running Title: A concise running title is required, with a maximum of 50 characters, excluding the author-name prefix used in AJTES page headers.

Editorial Assessment and Peer Review

All Narrative Reviews undergo preliminary editorial assessment to evaluate scientific relevance, originality of synthesis, completeness of the literature discussion, balance of evidence, clarity, and compliance with journal requirements.

Manuscripts considered suitable undergo external double-anonymized peer review, ordinarily involving at least two independent reviewers.

Reviewers may consider the SANRA framework when assessing the quality of the manuscript.

The final editorial decision is based on scientific quality, clinical or educational relevance, strength of critical analysis, reviewer recommendations, and compliance with AJTES editorial policies.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Review Article (Narrative Review)

Word Limit

Up to 4,500 words

Abstract

Required; maximum 350 words.

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6, preferably MeSH-aligned

References

Up to 150

Tables and Figures

Up to 6 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

3–5; maximum 85 characters each, including spaces

Manuscript Structure

Introduction, Thematic Discussion, Clinical/Surgical Implications, Limitations, Conclusions

Literature Search Description

Recommended

Reporting Guideline

No mandatory guideline specific to Narrative Reviews

Quality-Assessment Framework

SANRA recommended

Reporting Checklist

Not routinely required

Protocol Registration

Not ordinarily required

Formal Risk-of-Bias Assessment

Not mandatory

Meta-Analysis

Not required

Ethical Approval

Not ordinarily required for reviews of published, non-identifiable literature

Informed Consent

Required where applicable for identifiable patient information

Author Contributions

Required

Conflict of Interest Statement

Required

Funding Statement

Required

Data Availability Statement

As applicable

Peer Review

Double-anonymized external peer review, ordinarily by at least two independent reviewers

 Word-count policy: The word limit applies to the main manuscript text, excluding the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to word, reference, or figure limits may be considered when scientifically justified and approved by the Editorial Office.

Case Reports

Case Report

Definition and Scope

Case Reports are original, clinically focused scholarly publications describing individual patient cases that provide novel, unusual, or particularly instructive insights relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

They aim to communicate valuable clinical observations, highlight diagnostic or therapeutic challenges, describe unexpected complications, or illustrate important lessons that may improve clinical reasoning, surgical decision-making, patient safety, and future research.

A publishable Case Report must provide a clearly identifiable educational or scientific contribution beyond the routine description of a clinical condition.

Although individual case observations may generate hypotheses and inform future research, they cannot independently establish causality, treatment effectiveness, or generalizable clinical recommendations.

Suitable Topics

Case Reports may address:

  • Rare traumatic injuries or emergency surgical conditions.
  • Unusual or atypical clinical presentations.
  • Diagnostic challenges, pitfalls, or unexpected findings.
  • Innovative surgical techniques or therapeutic approaches.
  • Uncommon postoperative or post-traumatic complications.
  • Unexpected clinical outcomes or adverse events.
  • Rare anatomical variations with surgical implications.
  • Unusual radiological, endoscopic, or histopathological findings.
  • Complex clinical decision-making in emergency or acute care settings.
  • Important clinical lessons arising from multidisciplinary management.

Reports describing common conditions managed conventionally, without a distinctive clinical observation or clear educational contribution, are generally not considered suitable for publication.

Scientific and Clinical Requirements

Case Reports must present an accurate, coherent, and sufficiently detailed account of the patient's clinical course.

Authors should clearly identify the educational significance of the case and distinguish directly observed clinical findings from interpretation or speculation.

The manuscript should provide:

  • Relevant patient information and clinical history.
  • Presenting symptoms and significant physical findings.
  • Diagnostic investigations and differential diagnoses.
  • Important diagnostic or therapeutic challenges.
  • Surgical or non-surgical interventions.
  • Clinical reasoning supporting major management decisions.
  • Post-treatment monitoring and follow-up.
  • Patient outcomes and any unexpected or adverse events.
  • A chronological clinical timeline.
  • Relevant comparisons with previously published literature.
  • A clear statement of the principal clinical learning points.

Patient information must be presented objectively, without unnecessary identifying details or unsupported causal conclusions.

Manuscript Structure

Case Reports must follow the CARE (CAse REport) reporting guidelines and include the following components:

1. Title Page

A separate title page containing the manuscript title, full author names, institutional affiliations, corresponding author information, and required declarations.

The title should clearly identify the manuscript as a Case Report.

2. Unstructured Abstract

Provide a concise summary of the clinical background, patient presentation, key diagnostic findings, management, outcome, and main educational message.

3. Keywords

Three to six relevant keywords, preferably aligned with Medical Subject Headings (MeSH). The term "Case Report" should be included.

4. Introduction

A brief presentation of the clinical problem, relevant scientific background, and the specific reason the case warrants publication.

5. Case Presentation

A detailed, chronological description of the clinical course, including:

  • Patient information and relevant medical history.
  • Presenting complaints and clinical findings.
  • Diagnostic assessment and differential diagnosis.
  • Relevant laboratory, imaging, or pathological findings.
  • Therapeutic interventions and surgical procedures.
  • Clinical timeline.
  • Follow-up, outcomes, and complications.

The clinical timeline should summarize the key events and may be presented as a table or figure.

6. Discussion

A critical interpretation of the clinical findings in the context of current scientific literature.

The discussion should emphasize diagnostic and therapeutic reasoning, the novelty or educational significance of the case, relevant limitations, and implications for clinical practice.

7. Conclusions

A concise summary of the principal clinical lesson and its potential relevance to diagnosis, treatment, surgical management, or patient safety.

8. Patient Perspective

A brief description of the patient's experience or perspective may be included when obtainable and appropriate.

9. Patient Consent Statement

An explicit declaration confirming that written informed consent for publication was obtained from the patient or an appropriately authorized legal representative, in accordance with AJTES policy.

10. Declarations

Applicable statements regarding ethical approval or exemption, informed consent, author contributions, conflicts of interest, funding, data availability, and other relevant disclosures.

11. References

Relevant scientific publications supporting the discussion and clinical interpretation.

Abstract Requirements

An unstructured abstract of up to 250 words is required.

Although no formal section headings are required, the abstract should include:

  • Clinical background and significance.
  • Principal patient presentation and findings.
  • Diagnostic assessment.
  • Therapeutic or surgical management.
  • Clinical outcome.
  • Main educational conclusion.

The abstract must accurately reflect the case and avoid unsupported generalizations.

Reporting Guidelines

All Case Reports must be prepared in accordance with the CARE reporting guidelines.

Authors must submit a completed CARE checklist identifying where the relevant reporting items are addressed in the manuscript.

The CARE framework includes:

  • Title and keywords.
  • Abstract and introduction.
  • Patient information and clinical findings.
  • Clinical timeline.
  • Diagnostic assessment.
  • Therapeutic interventions.
  • Follow-up and outcomes.
  • Discussion.
  • Patient perspective, where obtainable.
  • Informed consent.

The manuscript must provide sufficient information to support clinical interpretation and methodological transparency.

PRISMA 2020 is not applicable to conventional Case Reports, as these publications do not constitute systematic reviews.

Patient Consent for Publication

Written informed consent for publication is mandatory for all Case Reports submitted to AJTES under the journal's proposed editorial policy.

Consent must be obtained from the patient or, where legally appropriate, an authorized representative before manuscript submission.

The consent must specifically address publication of the clinical information and any relevant images, with an explanation of the potential availability of the publication online.

Consent for treatment or hospital admission does not automatically constitute consent for scientific publication.

Authors must confirm that appropriate written consent has been obtained and retained in accordance with applicable institutional, legal, and journal requirements.

The Editorial Office may request documentary verification of consent.

Where valid publication consent cannot be obtained, the Case Report will not be considered for publication under this AJTES policy.

Patient Confidentiality and Image Anonymization

All direct and indirect patient identifiers must be removed unless disclosure is scientifically essential, legally permissible, and specifically covered by appropriate consent.

Identifying information includes:

  • Patient names, initials, and identification numbers.
  • Dates of birth and unnecessary identifying dates.
  • Hospital registration numbers.
  • Facial or other recognizable characteristics.
  • Identifying details within clinical photographs.
  • Burned-in information on CT, MRI, radiographic, or ultrasound images.
  • Identifying metadata contained in digital files.

Masking the eyes in a facial photograph is not considered sufficient to ensure patient anonymity.

Image processing must preserve diagnostic and anatomical accuracy and must not misrepresent the clinical findings.

Ethical Approval

Case Reports must comply with applicable institutional ethics requirements, national legislation, and international principles of medical publication ethics.

Formal ethics committee approval is not universally required for every individual Case Report.

Authors must state whether ethical approval was required and, where applicable, provide the name of the approving ethics committee, approval number, and date.

When the responsible institution or ethics committee has determined that approval is unnecessary or an exemption applies, the manuscript should report that determination.

Ethics committee approval and patient consent for publication are separate requirements.

Protocol Registration

Protocol registration is not ordinarily required for conventional Case Reports.

Case Reports are descriptive clinical publications and do not normally meet the criteria for prospective registration of a clinical trial or systematic review protocol.

If a submission includes an interventional clinical study or another design requiring registration, the manuscript should be submitted under the appropriate article category and comply with the corresponding registration requirements.

Clinical Images, Tables, and Figures

Clinical photographs, diagnostic images, operative illustrations, and pathological figures must be original or appropriately licensed, scientifically accurate, and of sufficient quality for publication.

All figures must be numbered consecutively, cited within the manuscript, and accompanied by informative legends.

Relevant anatomical structures, pathological findings, and surgical details should be clearly identified where appropriate.

Tables should provide information that supports the clinical narrative without unnecessary duplication.

Highlights and Running Title

Highlights: Authors must provide 3–5 concise statements summarizing the principal clinical observations or educational lessons. Each highlight must not exceed 85 characters, including spaces.

Running Title: A concise running title is required, with a maximum of 50 characters, excluding the author-name prefix used in AJTES page headers.

Editorial Assessment and Peer Review

All Case Reports undergo preliminary editorial screening to assess clinical relevance, originality, educational value, reporting completeness, ethical compliance, and adherence to journal requirements.

Manuscripts considered suitable for further evaluation undergo double-anonymized external peer review, ordinarily involving at least two independent reviewers.

The final editorial decision is based on clinical significance, scientific accuracy, educational contribution, completeness of reporting, reviewer recommendations, and compliance with AJTES editorial policies.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Case Report

Word Limit

Up to 2,500 words

Abstract

Required; maximum 250 words

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6, preferably MeSH-aligned; include "Case Report"

References

Up to 20

Tables and Figures

Up to 4 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

3–5; maximum 85 characters each, including spaces

Manuscript Structure

Introduction, Case Presentation, Discussion, Conclusions

Clinical Timeline

Required

Reporting Guideline

CARE Guidelines

Reporting Checklist

Completed CARE checklist required

Protocol Registration

Not required for conventional Case Reports

Ethical Approval

According to applicable institutional and legal requirements

Patient Consent for Publication

Mandatory under AJTES editorial policy

Patient Confidentiality

Mandatory

Patient Perspective

Recommended when obtainable

Author Contributions

Required

Conflict of Interest Statement

Required

Funding Statement

Required

Data Availability Statement

As applicable

Peer Review

Double-anonymized external peer review, ordinarily by at least two independent reviewers

 Word-count policy: The word limit applies to the main manuscript text and excludes the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to word, reference, or figure limits may be considered when scientifically justified and approved by the Editorial Office.

Short Report

Definition and Scope

Short Reports are concise, original scientific contributions presenting focused, methodologically sound, and clinically or scientifically relevant research findings that can be communicated effectively within a shorter manuscript format.

This category is intended for small but complete studies, focused clinical investigations, preliminary findings supported by adequate data, methodological evaluations, or narrowly defined research questions that warrant timely scientific communication.

Short Reports may include original clinical, epidemiological, observational, experimental, translational, or health-services research relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

Unlike Original Research Articles, Short Reports emphasize a limited number of clearly defined research objectives and principal findings. However, they must meet the same fundamental standards of scientific validity, methodological transparency, ethical compliance, statistical rigor, and research integrity.

A Short Report is a condensed research article, not an incomplete study.

Suitable Study Designs and Topics

Short Reports may include:

  • Focused prospective or retrospective clinical studies.
  • Small-scale observational investigations.
  • Pilot and feasibility studies with clearly defined objectives.
  • Preliminary findings supported by complete and appropriately analyzed data.
  • Focused epidemiological investigations.
  • Clinical outcomes and quality improvement research.
  • Diagnostic or methodological evaluations.
  • Brief analyses of institutional registries or clinical datasets.
  • Experimental or translational investigations.
  • Focused evaluations of surgical techniques, diagnostic pathways, or clinical management strategies.

Submissions must demonstrate scientific originality, clinical relevance, and sufficient methodological completeness to support the reported findings.

Preliminary results should be clearly identified as such, and conclusions must remain proportionate to the sample size, study design, and strength of the evidence.

Scientific and Methodological Requirements

Short Reports must address a clearly defined research question or hypothesis and provide sufficient methodological detail to permit critical appraisal and interpretation.

Authors should describe the study design, setting, population or experimental material, eligibility criteria, data collection methods, primary outcomes, and statistical analyses, as applicable.

The manuscript should report:

  • A clearly defined study objective or hypothesis.
  • An appropriate and transparent research design.
  • A description of the study population and selection criteria.
  • Clearly defined outcome measures.
  • Appropriate statistical methods and numerical findings.
  • Relevant measures of uncertainty, where applicable.
  • Study limitations and potential sources of bias.
  • Conclusions directly supported by the reported results.

Authors must not omit essential methodological information or selectively report findings solely to meet the prescribed word limit.

Where additional methodological information is necessary, supplementary materials may be submitted in accordance with AJTES policies.

Manuscript Structure

Short Reports should generally follow a condensed IMRaD structure (Introduction, Methods, Results, and Discussion).

The recommended components are:

1. Title Page

Manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.

2. Unstructured Abstract

A concise summary of the study background, objective, methods, principal results, and conclusions, presented as continuous prose.

3. Keywords

Three to six relevant keywords, preferably aligned with Medical Subject Headings (MeSH).

4. Introduction

A brief explanation of the scientific background, knowledge gap, clinical relevance, and research objective.

5. Materials and Methods

A focused but sufficiently detailed description of study design, setting, participants, selection criteria, interventions or measurements, outcome definitions, statistical analyses, and ethical considerations.

6. Results

Objective presentation of the principal findings, supported by relevant numerical data, statistical estimates, tables, or figures.

7. Discussion

Concise interpretation of the findings in relation to existing evidence, clinical implications, methodological limitations, and potential directions for further research.

8. Conclusions

A brief statement of the principal findings and their scientific or clinical relevance, avoiding unsupported generalizations.

9. Declarations

Applicable statements concerning ethical approval, informed consent, trial registration, author contributions, funding, conflicts of interest, data availability, and other required disclosures.

10. References

A focused selection of relevant and scientifically reliable references supporting the study.

Abstract Requirements

An unstructured abstract of up to 250 words is required.

Although formal headings are not required, the abstract should clearly communicate:

  • The scientific or clinical background.
  • The primary research objective.
  • The study design and essential methods.
  • The principal findings, including relevant numerical results.
  • The main conclusions and their clinical or scientific implications.

The abstract must be presented as continuous prose without mandatory section headings.

It must accurately reflect the manuscript and should not include conclusions unsupported by the reported data.

For registered clinical trials, the trial registration information must be reported in accordance with applicable ICMJE recommendations.

Research Reporting Guidelines

Short Reports must follow the internationally recognized reporting guideline appropriate to the underlying study design.

Applicable guidelines include:

  • CONSORT 2025: Randomized controlled trials.
  • STROBE: Observational studies, including cohort, case-control, and cross-sectional studies.
  • STARD: Diagnostic accuracy studies.
  • TREND: Nonrandomized evaluations of behavioral and public health interventions, where applicable.
  • ARRIVE 2.0: Animal research.
  • TRIPOD / TRIPOD+AI: Clinical prediction model studies, including applicable artificial intelligence models.
  • SQUIRE 2.0: Healthcare quality improvement studies, where applicable.

Authors must submit the appropriate reporting checklist when required by the study design.

The shortened article format does not exempt authors from reporting essential methodological and statistical information.

PRISMA 2020 is not routinely applicable to Short Reports presenting primary research. Manuscripts primarily reporting a systematic review or meta-analysis should be submitted under the corresponding article category.

Protocol Registration

Prospective registration is required for clinical trials meeting the applicable ICMJE definition and registration requirements.

The trial registry name, registration number, and relevant registration details must be provided.

For observational studies and other non-trial investigations, protocol registration is encouraged where appropriate but is not ordinarily mandatory unless required by applicable regulations, funding conditions, or journal policy.

Authors should identify any registered protocol or prespecified analysis plan when available.

Ethical Approval and Informed Consent

All Short Reports must comply with applicable national and international research ethics requirements, including the principles of the Declaration of Helsinki for research involving human participants.

The manuscript must identify the responsible ethics committee or institutional review board and provide the approval number and date, where applicable.

Where ethics approval was waived or an exemption was granted, the responsible authority and the basis for that decision must be documented.

Informed consent requirements must be addressed according to the study design, applicable legislation, and institutional regulations.

Any approved waiver of informed consent must be clearly reported.

Research involving animals must comply with applicable institutional and national animal welfare requirements.

Patient confidentiality must be maintained, and identifiable clinical information or images must not be published without the appropriate authorization and consent.

Statistical Reporting and Data Transparency

Statistical analyses must be appropriate to the research design and sample size.

Authors should report relevant numerical findings, effect estimates, confidence intervals, and other measures of uncertainty when applicable.

Statistical significance should not be presented as a substitute for clinical relevance.

Authors must identify important methodological limitations, potential confounding, missing data, and sources of bias.

A data availability statement must be provided in accordance with applicable ethical, legal, and institutional restrictions.

Highlights and Running Title

Highlights: Authors must provide 3–5 concise statements summarizing the principal findings or clinical implications. Each highlight must not exceed 85 characters, including spaces.

Running Title: A concise running title is required, with a maximum of 50 characters, excluding the author-name prefix used in AJTES page headers.

Editorial Assessment and Peer Review

All Short Reports undergo preliminary editorial screening to assess scientific originality, clinical relevance, methodological completeness, ethical compliance, and adherence to journal requirements.

Manuscripts considered suitable for further evaluation undergo double-anonymized external peer review, ordinarily involving at least two independent reviewers.

The final editorial decision is based on scientific quality, methodological validity, clinical relevance, reviewer recommendations, and compliance with AJTES editorial policies.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Short Report (Brief Research Report)

Word Limit

Up to 2,000 words

Abstract

Required; maximum 250 words

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6, preferably MeSH-aligned

References

Up to 20

Tables and Figures

Up to 3 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

3–5; maximum 85 characters each, including spaces

Manuscript Structure

Condensed IMRaD: Introduction, Materials and Methods, Results, Discussion, Conclusions

Reporting Guideline

CONSORT, STROBE, STARD, TREND, ARRIVE, TRIPOD, or SQUIRE, as applicable

Reporting Checklist

Required according to study design

PRISMA Flow Diagram

Not applicable to primary research Short Reports

PRISMA Checklist

Not applicable to primary research Short Reports

Protocol Registration

Required for applicable clinical trials; encouraged for other eligible studies

Ethical Approval

Required where applicable; documented exemptions or waivers accepted

Informed Consent

Required where applicable; approved waivers must be documented

Statistical Analysis

Required where appropriate to study design

Author Contributions

Required

Conflict of Interest Statement

Required

Funding Statement

Required

Data Availability Statement

Required

Peer Review

Double-anonymized external peer review, ordinarily by at least two independent reviewers

Word-count policy: The word limit applies to the main manuscript text, excluding the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to the prescribed word, reference, or figure limits may be considered when scientifically justified and approved by the Editorial Office.

Commentary Article

Definition and Scope

Commentary Articles are concise, focused, and evidence-informed scholarly contributions that provide critical interpretation, contextual analysis, or expert discussion of recently published research, emerging scientific developments, or significant clinical and professional issues relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

Commentaries aim to place new scientific findings or developments within the broader context of current evidence, clarify their implications for clinical practice, stimulate constructive academic discussion, and identify unresolved questions or areas requiring further investigation.

Unlike Original Research Articles, Commentaries do not ordinarily present new empirical research findings. Unlike conventional Narrative Reviews, they focus on a specific scientific development, publication, controversy, or emerging issue rather than providing a comprehensive overview of an entire field.

Commentary Articles are generally commissioned by the Editor-in-Chief or Editorial Board. Unsolicited submissions may be considered in exceptional circumstances when they offer substantial scientific or clinical relevance.

Types of Commentary

AJTES accepts two principal forms of Commentary Articles:

1. Article-Focused Commentary

These articles critically discuss one or more recently published scientific papers, emphasizing the interpretation, limitations, clinical implications, and potential impact of the reported findings.

Authors should move beyond summarizing the original publication and provide an independent, evidence-informed evaluation of its scientific or clinical significance.

2. Topic-Focused Commentary

These articles address important developments, emerging controversies, or changes in clinical practice, technology, healthcare organization, surgical education, or scientific policy.

Suitable topics include new surgical technologies, evolving treatment strategies, changes in clinical guidelines, patient safety initiatives, trauma systems, and emerging challenges in emergency surgical care.

Scientific and Editorial Requirements

Commentary Articles must present a clear central message supported by relevant and reliable scientific evidence.

Authors should critically interpret the available literature, acknowledge important limitations or uncertainties, and discuss relevant alternative perspectives fairly.

Commentaries should emphasize the implications of scientific developments rather than merely restating published findings.

The discussion should reflect the relevant evidence available at the time of submission, including peer-reviewed publications and accepted in-press articles when appropriate and adequately identifiable.

Authors must avoid selective citation, disproportionate emphasis on their own publications or those of close collaborators, unsupported claims, and promotional language.

Recommendations should be proportionate to the strength and certainty of the supporting evidence.

Manuscript Structure

Commentary Articles should follow a concise narrative format with optional thematic subheadings.

The recommended components are:

  1. Title Page: Manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.
  2. Unstructured Abstract: A concise summary of the scientific issue, central interpretation, and principal clinical or research implications.
  3. Keywords: Three to six relevant terms, preferably aligned with Medical Subject Headings (MeSH).
  4. Introduction: Identification of the publication or development being discussed, its scientific context, and the principal objective of the commentary.
  5. Critical Discussion: Evidence-informed interpretation, methodological or clinical considerations, relevant limitations, alternative perspectives, and implications for practice or research.
  6. Conclusions or Future Directions: A concise statement of the main message and its relevance to clinical practice, scientific research, or healthcare policy.
  7. Declarations: Author contributions, conflicts of interest, funding, and other applicable disclosures.
  8. References: Relevant scientific publications supporting the discussion.

A conventional IMRaD structure is not required.

Abstract Requirements

An unstructured abstract of up to 250 words is required.

The abstract should briefly describe the scientific publication, clinical issue, or emerging development being addressed; explain the central interpretation; and summarize the principal implications.

The abstract must be written as continuous prose without mandatory section headings.

It should accurately reflect the content and must not imply that original research was performed when the article consists of scholarly commentary.

Reporting Guidelines

There is no universally mandated reporting checklist specifically designed for conventional Commentary Articles.

Study-specific reporting guidelines, including CONSORT, STROBE, STARD, CARE, and PRISMA, are not routinely applicable to commentaries that do not report original research or systematic evidence synthesis.

If a manuscript presents substantial original data, a formal systematic review, or a meta-analysis, it should be submitted under the appropriate research or review article category.

PRISMA flow diagrams, PRISMA checklists, and systematic review protocol registration are not required for conventional Commentary Articles.

Publication-Based Commentary

When a Commentary discusses a specific published article, the original publication must be clearly identified and appropriately cited.

The Commentary should provide an independent interpretation of the publication and explain its relevance, limitations, or implications without reproducing substantial portions of the original text.

Where appropriate, the journal may establish electronic bibliographic links between the Commentary and the article being discussed.

When a submission primarily raises direct questions or substantive criticism concerning a specific AJTES publication, the Editorial Office may classify it as a Letter to the Editor to allow the original authors an appropriate opportunity to respond.

Ethical Standards and Conflicts of Interest

All Commentary Articles must comply with AJTES policies on publication ethics, authorship, research integrity, transparency, editorial independence, confidentiality, and responsible scientific communication.

Authors must disclose all relevant financial and non-financial relationships, institutional affiliations, professional interests, funding sources, and other activities that could influence, or reasonably be perceived to influence, their interpretation of scientific evidence.

Relevant relationships involving pharmaceutical products, medical devices, surgical technologies, professional organizations, healthcare institutions, or clinical guidelines discussed in the manuscript must be explicitly declared.

Commentaries must distinguish the authors' professional interpretations from official statements of AJTES or affiliated organizations unless explicitly designated as such.

Ethics committee approval is not ordinarily required for conventional Commentaries that do not report original research involving human participants, animals, or protected data.

Any inclusion of identifiable patient information must comply with applicable confidentiality and informed consent requirements.

Editorial Assessment and Peer Review

Commentary Articles undergo preliminary editorial assessment by the Editor-in-Chief or a designated member of the Editorial Board.

The assessment considers scientific relevance, originality of interpretation, factual accuracy, quality of supporting evidence, balance, clarity, ethical compliance, and suitability for the journal's readership.

External peer review may be requested at the discretion of the handling editor, particularly when a Commentary addresses complex scientific evidence, disputed clinical recommendations, or clinically consequential developments.

Commentaries authored by editors or Editorial Board members must be handled by an independent editor without relevant conflicts of interest.

The final editorial decision rests with the responsible handling editor.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Commentary Article

Word Limit

Up to 2,000 words

Abstract

Required; maximum 250 words

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6

References

Up to 40

Tables and Figures

Up to 2 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

Optional

Manuscript Structure

Introduction, Critical Discussion, Conclusions or Future Directions

Reporting Guideline

No specific reporting guideline routinely required

Reporting Checklist

Not routinely required

PRISMA Flow Diagram

Not applicable

PRISMA Checklist

Not applicable

Protocol Registration

Not required for conventional Commentary Articles

Ethical Approval

Not ordinarily required unless original research involving human participants, animals, or protected data is included

Informed Consent

Required where applicable, particularly for identifiable patient information

Conflict of Interest Statement

Required

Funding Statement

Required

Author Contributions

Required

Data Availability Statement

Not ordinarily required unless original datasets are reported

Original Article Citation

Required for Article-Focused Commentaries

Submission

Preferably by invitation; unsolicited submissions considered selectively

Peer Review

Editorial assessment; external peer review at the editor's discretion

Editorial Independence

Independent handling required for editor-authored submissions

Word-count policy: The word limit applies to the main manuscript text and excludes the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to word, reference, or figure limits may be considered when scientifically justified and approved by the responsible editor.

Authors should give a balanced account of the field, discuss work that is published or in press at the time of writing, and not concentrate on their own work or that of close colleagues. A conflict-of-interest declaration is mandatory.

Structure. Continuous prose with an unstructured abstract; no IMRaD headings.

Limits and review. Word limit: up to 2,000 words (excluding title page, abstract, references, tables, and figure legends). Abstract: unstructured, up to 250 words. References: up to 40. Tables and figures: up to 2. Peer review: assessed by the Editor-in-Chief or a member of the Editorial Board, and sent for external peer review at the editors' discretion.

Perspective Article

Perspective Article

Definition and Scope

Perspective Articles are scholarly, evidence-informed contributions that provide a critical, forward-looking interpretation of important clinical, scientific, educational, ethical, organizational, or healthcare-policy issues relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

These articles allow clinicians, researchers, educators, and healthcare professionals to critically examine emerging developments, reassess established concepts, identify gaps in current knowledge, and propose directions for future research, clinical practice, professional education, or healthcare system improvement.

Unlike Opinion Articles, which primarily advance and defend a particular professional position, Perspective Articles emphasize contextual analysis, interpretation of evolving evidence, and exploration of future opportunities, challenges, and strategic priorities.

Perspective Articles should be grounded in relevant peer-reviewed literature and scientifically credible evidence rather than personal experience or unsupported assertions alone.

Suitable Topics

Perspective Articles may address:

  • Emerging concepts and evolving strategies in trauma and emergency surgery.
  • Developments in acute care surgery, critical care, and multidisciplinary emergency management.
  • Advances in diagnostic technologies, minimally invasive surgery, and surgical innovation.
  • Trauma systems, regionalization of care, and healthcare organizational models.
  • Patient safety, quality improvement, and healthcare outcomes.
  • Surgical education, competency-based training, simulation, and professional development.
  • Clinical practice guidelines, evidence gaps, and future research priorities.
  • Ethical challenges in emergency surgical decision-making.
  • Artificial intelligence, digital health, and technological transformation in surgical practice.
  • Global surgery, health inequalities, and access to emergency surgical care.
  • Future directions in translational research, precision medicine, and evidence-based surgical practice.

Submissions must demonstrate scientific relevance, intellectual originality, balanced critical analysis, and potential implications for the journal's readership.

Scientific and Editorial Requirements

Perspective Articles should present a clearly defined central theme or analytical question and develop a coherent, evidence-informed discussion.

Authors must critically interpret the available scientific literature, distinguish established findings from emerging hypotheses or expert interpretation, and acknowledge relevant limitations, uncertainties, and competing perspectives.

The manuscript should identify important knowledge gaps, unresolved questions, or limitations of current clinical practice and explain their implications for future developments.

Recommendations and proposed directions must be proportionate to the available evidence and should not be presented as established clinical standards when supporting evidence is insufficient.

Original research data and formal statistical analyses are not ordinarily required. However, use published quantitative evidence, comparative information, conceptual models, and explanatory figures when relevant.

Perspective Articles should offer a meaningful contribution beyond summarizing existing literature by providing critical insight, conceptual interpretation, or a justified vision for future practice or research.

Manuscript Structure

Perspective Articles should follow a flexible narrative structure with thematic subheadings where appropriate.

The recommended components are:

  1. Title Page: Manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.
  2. Unstructured Abstract: A concise summary of the topic, central perspective, supporting evidence, and principal implications.
  3. Keywords: Three to six relevant terms, preferably aligned with Medical Subject Headings (MeSH).
  4. Introduction: Scientific or clinical background, significance of the topic, current challenges, and the central purpose of the article.
  5. Current Evidence and Context: Critical interpretation of relevant literature, established knowledge, emerging developments, and existing controversies.
  6. Critical Analysis and Perspectives: Discussion of competing interpretations, limitations, knowledge gaps, and potential implications.
  7. Future Directions and Clinical Implications: Proposed priorities for clinical practice, research, education, innovation, or healthcare policy.
  8. Conclusions: A concise synthesis of the principal perspectives and their potential significance.
  9. Declarations: Author contributions, conflicts of interest, funding, and other applicable disclosures.
  10. References: Relevant and accurately cited scientific literature supporting the discussion.

A conventional IMRaD structure is not required.

Abstract Requirements

An unstructured abstract of up to 250 words is required.

The abstract should briefly describe:

  • The clinical, scientific, or organizational issue being addressed.
  • The current context or evidence gap.
  • The central interpretation or perspective.
  • The principal implications or proposed future directions.

The abstract must be presented as continuous prose without mandatory section headings.

It should accurately reflect the manuscript and avoid unsupported claims or conclusions.

Reporting Guidelines

There is no universally mandated research-reporting checklist specifically designed for conventional Perspective Articles.

Study-specific reporting guidelines, including CONSORT, STROBE, STARD, CARE, and PRISMA, are not routinely applicable to Perspective Articles that provide scholarly analysis without reporting original research or conducting a systematic evidence synthesis.

Authors should cite and critically interpret the relevant literature accurately and transparently.

If a manuscript primarily presents original empirical findings, a systematic review, or a quantitative meta-analysis, it should be submitted under the appropriate research or review article category.

A PRISMA flow diagram, PRISMA checklist, and systematic review protocol registration are not required for conventional Perspective Articles.

Ethical Standards and Conflicts of Interest

All Perspective Articles must comply with AJTES policies on publication ethics, authorship, originality, research integrity, transparency, confidentiality, and editorial independence.

Authors must disclose relevant financial and non-financial relationships, professional affiliations, institutional interests, funding sources, and other activities that may influence, or reasonably be perceived to influence, the interpretation of evidence or recommendations.

Particular attention should be given to relevant relationships involving medical devices, pharmaceutical products, surgical technologies, professional organizations, healthcare institutions, or policy initiatives discussed in the manuscript.

Perspective Articles should clearly distinguish the authors' scholarly interpretations from official positions of AJTES or affiliated institutions unless explicitly authorized and designated as such.

Ethics committee approval is not ordinarily required for conventional Perspective Articles that do not involve original research with human participants, animals, or protected data.

Any identifiable patient information must comply with applicable confidentiality and informed consent requirements.

Editorial Assessment and Peer Review

All Perspective Articles undergo preliminary editorial assessment by the Editor-in-Chief or a designated member of the Editorial Board.

The assessment considers scientific relevance, originality of perspective, quality and balance of supporting evidence, clarity of analysis, academic contribution, ethical compliance, and adherence to journal requirements.

External peer review may be requested at the handling editor's discretion, particularly when the manuscript addresses complex scientific evidence, controversial clinical recommendations, emerging technologies, or consequential healthcare-policy proposals.

Perspective Articles authored by editors or Editorial Board members must be handled by an independent editor without relevant conflicts of interest.

The final decision regarding publication rests with the responsible editor.

Manuscript Requirements

 

Requirement

AJTES Standard

Article Type

Perspective Article

Word Limit

Up to 2,500 words

Abstract

Required; maximum 250 words.

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6

References

Up to 30

Tables and Figures

Up to 2 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

Optional

Manuscript Structure

Introduction, Current Evidence and Context, Critical Analysis, Future Directions, Conclusions

Reporting Guideline

No specific reporting guideline routinely required

Reporting Checklist

Not routinely required

PRISMA Flow Diagram

Not applicable

PRISMA Checklist

Not applicable

Protocol Registration

Not required for conventional Perspective Articles

Ethical Approval

Not ordinarily required unless original research involving human participants, animals, or protected data is included

Informed Consent

Required where applicable, particularly for identifiable patient information

Conflict of Interest Statement

Required

Funding Statement

Required

Author Contributions

Required

Data Availability Statement

Not ordinarily required unless original datasets are reported

Submission

Open submission; invited contributions also accepted

Peer Review

Editorial assessment; external peer review at the editor's discretion

Editorial Independence

Independent handling required for editor-authored submissions

Word-count policy: The word limit applies to the main manuscript text and excludes the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to word, reference, and figure limits may be considered when scientifically justified and approved by the responsible editor.

Opinion Article

Opinion Article

Definition and Scope

Opinion Articles are concise, evidence-informed scholarly contributions that present a clearly articulated and critically reasoned professional viewpoint on significant clinical, scientific, educational, ethical, organizational, or health-policy issues relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

These articles provide experienced clinicians, researchers, educators, and healthcare professionals a forum to interpret existing evidence critically, challenge established clinical practices, address emerging controversies, and propose perspectives that may stimulate scientific discussion or improve patient care.

Unlike Original Research Articles, Opinion Articles are not intended to report new empirical research findings. Their primary purpose is to develop and defend a well-supported argument based on existing scientific evidence, clinical expertise, and transparent professional reasoning.

Suitable Topics

Opinion Articles may address:

  • Controversial or evolving clinical practices in trauma and emergency surgery.
  • Critical interpretation of current scientific evidence or clinical guidelines.
  • Emerging challenges in surgical decision-making and patient safety.
  • Ethical dilemmas in trauma, emergency surgery, and critical care.
  • Healthcare policy, trauma systems, and emergency preparedness.
  • Surgical education, professional training, and competency development.
  • Healthcare quality, resource allocation, and organizational priorities.
  • Research methodology, scientific integrity, and publication ethics.
  • Emerging technologies, innovation, and artificial intelligence in surgical practice.
  • Unresolved clinical questions and priorities for future research.

Submissions should address topics of substantial relevance to the journal's readership and contribute to informed scientific or professional debate.

Scientific and Editorial Requirements

Opinion Articles must present a clear central position supported by relevant, accurate, and appropriately cited scientific literature.

Authors should distinguish established evidence from professional interpretation, clinical experience, hypotheses, and personal viewpoints.

Arguments must be logically developed, scientifically credible, and balanced. Relevant alternative perspectives, limitations, uncertainties, and opposing evidence should be acknowledged and discussed fairly.

Recommendations must be proportionate to the strength and certainty of the available evidence. Unsupported claims, selective citation, exaggerated conclusions, and promotional or commercially influenced arguments are not acceptable.

Opinion Articles should offer meaningful implications for clinical practice, research, professional education, healthcare organization, or health policy.

Manuscript Structure

Opinion Articles should generally follow a flexible narrative structure with optional thematic subheadings.

The recommended components are:

  1. Title Page: Manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.
  2. Unstructured Abstract: A concise summary of the topic, central position, supporting rationale, and principal implications.
  3. Keywords: Three to six relevant terms, preferably aligned with Medical Subject Headings (MeSH).
  4. Introduction: Background, significance of the issue, existing controversy or knowledge gap, and the author's central position.
  5. Main Discussion: Critical interpretation of the scientific evidence, principal arguments, relevant alternative perspectives, and clinical or professional implications.
  6. Conclusions or Recommendations: A concise synthesis of the author's position, its implications, and potential directions for practice, research, or policy.
  7. Declarations: Author contributions, conflicts of interest, funding, and other applicable disclosures.
  8. References: Relevant, accurate, and preferably current scientific literature supporting the arguments.

A conventional IMRaD structure is not required.

Abstract Requirements

An unstructured abstract of up to 250 words is required.

The abstract should briefly identify the clinical or scientific issue, state the central position, summarize the supporting rationale, and highlight the principal implications.

The abstract must be presented as continuous prose without mandatory section headings.

It should accurately reflect the article's arguments and must not imply that original research was conducted unless such research is separately reported in an appropriate manuscript category.

Reporting Guidelines

There is no universally mandated study-reporting checklist specifically developed for conventional Opinion Articles.

Study-specific reporting guidelines, including CONSORT, STROBE, STARD, CARE, and PRISMA, are not routinely applicable to opinion-based scholarly commentary.

If a manuscript presents substantial original research findings, a formal systematic review, or quantitative evidence synthesis, it should be submitted under the appropriate research or review article category.

A PRISMA flow diagram, PRISMA checklist, and systematic review protocol registration are not required for conventional Opinion Articles.

Ethical Standards and Conflicts of Interest

All Opinion Articles must comply with AJTES policies on publication ethics, authorship, editorial independence, scientific integrity, confidentiality, and responsible scholarly communication.

Authors must disclose all relevant financial and non-financial relationships, institutional interests, professional affiliations, and other activities that could influence, or reasonably be perceived to influence, the arguments presented.

When an article discusses specific pharmaceutical products, medical devices, commercial technologies, institutions, professional organizations, or healthcare policies, authors must explicitly declare any relevant relationships or interests.

The presence of a disclosed relationship does not automatically preclude publication; however, transparency is mandatory, and the Editorial Office may require additional disclosures or independent assessment.

Submissions involving identifiable patient information must comply with applicable confidentiality, consent, and ethical requirements.

Opinion Articles must clearly distinguish the views of the authors from official statements of AJTES or affiliated institutions unless explicitly authorized and designated as such.

Editorial Assessment and Peer Review

All Opinion Articles undergo preliminary editorial assessment by the Editor-in-Chief or a designated member of the Editorial Board.

The assessment considers relevance to the journal's scope, scientific accuracy, clarity of argument, balanced interpretation, originality of perspective, ethical compliance, and adherence to manuscript requirements.

External peer review may be requested at the handling editor's discretion, particularly when the manuscript addresses controversial clinical practices, complex scientific evidence, potentially consequential policy recommendations, or disputed scientific questions.

Manuscripts authored by editors or Editorial Board members must be assigned to an independent handling editor without relevant conflicts of interest.

The final publication decision rests with the responsible editor.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Opinion Article

Word Limit

Up to 2,000 words

Abstract

Required; maximum 250 words.

Abstract Model

Unstructured

Abstract Headings

Not required

Keywords

3–6

References

Up to 20

Tables and Figures

Up to 2 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

Optional

Manuscript Structure

Introduction, Main Discussion, Conclusions or Recommendations

Reporting Guideline

No specific reporting guideline routinely required

Reporting Checklist

Not routinely required

Protocol Registration

Not required for conventional Opinion Articles

Ethical Approval

Not ordinarily required for commentary without original human or animal research

Informed Consent

Required where applicable, particularly for identifiable patient information

Conflict of Interest Statement

Required

Funding Statement

Required

Author Contributions

Required

Data Availability Statement

Not ordinarily required; applicable if original datasets are reported.

Submission

Open submission; editorial invitation also accepted

Peer Review

Editorial assessment; external peer review at the editor's discretion

Editorial Independence

Independent handling required for editor-authored submissions

 

 

Word-count policy: The word limit applies to the main manuscript text and excludes the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to the prescribed word, reference, or figure limits may be considered when scientifically justified and approved by the responsible editor.

Letter to the Editor

Letter to the Editor

Definition and Scope

Letters to the Editor are concise, evidence-informed scholarly communications that provide constructive comments, critical appraisal, scientific clarification, or alternative interpretations of articles previously published in the Albanian Journal of Trauma and Emergency Surgery (AJTES).

Letters may also address focused clinical, scientific, methodological, ethical, or educational issues of particular relevance to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

This article category aims to promote transparent post-publication scientific discussion, encourage constructive academic debate, and strengthen the accuracy, interpretation, and clinical relevance of published research.

Suitable Content

Letters to the Editor may include:

  • Constructive criticism or clarification of recently published AJTES articles.
  • Discussion of methodological limitations or statistical interpretation.
  • Alternative interpretations of previously reported findings.
  • Questions concerning diagnostic, therapeutic, or surgical approaches.
  • Brief evidence-informed observations of clinical or scientific relevance.
  • Comments on current guidelines, clinical recommendations, or emerging evidence.
  • Clarification of important scientific, educational, or professional issues.

Letters must be focused, scientifically justified, professionally written, and supported by relevant references where appropriate.

Submissions containing personal criticism, defamatory statements, unsupported allegations, or inappropriate language will not be considered.

Letters reporting substantial original research findings, comprehensive case reports, or systematic evidence syntheses should be submitted under the appropriate article category.

Manuscript Structure

Letters to the Editor should follow a concise narrative format and generally include:

  1. Title Page: Manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.
  2. Opening Statement: Identification of the article being discussed, where applicable, and a clear statement of the purpose of the letter.
  3. Main Discussion: Focused scientific arguments, critical observations, methodological comments, or clinical interpretations supported by appropriate evidence.
  4. Concluding Statement: A concise summary of the principal message, clarification, or recommendation.
  5. Declarations: Author contributions, conflicts of interest, funding, and other applicable disclosures.
  6. References: Relevant scientific references, including the original AJTES article when the letter comments on a published publication.

A structured abstract and conventional IMRaD organization are not required.

Correspondence Concerning Published Articles

Letters that raise substantive scientific or methodological criticism of an AJTES article will ordinarily be forwarded to the corresponding author of the original publication for an opportunity to respond.

The Editorial Office will assess both the letter and any author response for scientific accuracy, relevance, clarity, and professional conduct.

When appropriate, the Letter to the Editor and the corresponding Author Reply may be published together or in a coordinated manner to facilitate balanced scientific discussion.

Each published item will be treated as a separate citable publication, with its own DOI when assigned, and linked electronically to the original article and related correspondence.

The editorial decision to publish a letter does not depend on the agreement of the authors of the original article. A letter may be published without an author reply when the original authors decline or do not respond within the specified period.

Research Integrity and Post-Publication Concerns

Letters addressing differences in scientific interpretation, methodological disagreement, or clinical opinion are considered part of legitimate post-publication academic discussion.

However, submissions raising concerns about possible data fabrication, falsification, plagiarism, serious ethical violations, or the reliability of published findings must be assessed under the journal's Research Integrity, Corrections and Retractions Policy.

Where appropriate, such concerns may require editorial investigation, institutional consultation, correction, an expression of concern, or retraction rather than publication solely as a Letter to the Editor.

Reporting Guidelines

There is no universally mandated reporting checklist specifically developed for conventional Letters to the Editor.

CONSORT, STROBE, STARD, CARE, and PRISMA are not routinely applicable to letters consisting solely of scientific commentary or post-publication discussion.

If a letter contains substantive original clinical research, patient-level data, or a formal evidence synthesis, the Editorial Office may require compliance with the relevant reporting guideline or recommend submission under another article category.

Ethical and Editorial Requirements

All submissions must comply with AJTES policies on authorship, originality, academic integrity, confidentiality, conflicts of interest, and responsible scientific communication.

Anonymous letters are not accepted for publication. The identity and institutional affiliation of all authors must be provided to the Editorial Office.

Letters must not contain confidential patient information or identifiable clinical details without the appropriate ethical authorization and informed consent for publication.

Authors must disclose relevant financial and non-financial conflicts of interest, funding sources, and other relationships that may influence the content.

Letters authored by editors or Editorial Board members must be handled independently in accordance with the journal's conflict-of-interest and editorial independence policies.

Editorial Assessment and Peer Review

All Letters to the Editor undergo editorial screening by the Editor-in-Chief or a designated member of the Editorial Board.

The evaluation considers scientific relevance, originality of argument, factual accuracy, constructive academic contribution, ethical compliance, and adherence to journal requirements.

External peer review may be requested at the discretion of the handling editor, particularly when a letter raises complex methodological, statistical, or clinically significant issues.

Authors of the original article will ordinarily be invited to respond when substantive criticism is raised.

The final decision regarding publication rests with the responsible editor.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Letter to the Editor

Word Limit

Up to 1,000 words

Abstract

Not required

Keywords

Optional; 3–5

References

Up to 10

Tables and Figures

Up to 1 combined

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

Not required

Manuscript Structure

Opening Statement, Main Discussion, Concluding Statement

Reporting Guideline

No specific guideline routinely required

Reporting Checklist

Not routinely required

Protocol Registration

Not required for conventional letters

Ethical Approval

Not ordinarily required for commentary without original research

Informed Consent

Required where applicable, particularly for identifiable patient information

Conflict of Interest Statement

Required

Funding Statement

Required

Author Contributions

Required

Original Article Citation

Required when commenting on a published AJTES article

Author Reply

Ordinarily invited for substantive criticism

Anonymous Submissions

Not accepted

Peer Review

Editorial assessment; external review when appropriate

Publication and DOI

Separate DOI for each published letter or reply, when assigned; links to related publications

Word-count policy: The word limit applies to the main text, excluding the title page, references, tables, and figure legends.

Editorial discretion: Exceptions to the prescribed word, reference, or figure limits may be considered when scientifically justified and approved by the responsible editor.

 

News and Updates

Definition and Scope

News and Updates are concise, informative, and editorially approved publications that communicate significant scientific, clinical, educational, professional, institutional, or public-health developments relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

This category provides timely, accurate, and accessible information to the journal's readership regarding important developments in clinical practice, scientific societies, professional education, research activities, healthcare organization, and academic publishing.

News and Updates are generally commissioned, prepared, or approved by the Editor-in-Chief or Editorial Board. Contributions from scientific societies, academic institutions, professional organizations, and individual experts may also be considered, subject to editorial approval.

Unlike Original Research Articles, News and Updates do not ordinarily present original research findings, formal scientific investigations, or systematic evidence syntheses.

Their primary purpose is scientific and professional communication rather than the generation of new empirical evidence.

Suitable Topics

News and Updates may include:

  • Reports from national and international scientific congresses, conferences, symposia, and workshops.
  • Updates on newly published clinical guidelines, consensus statements, and professional recommendations.
  • Activities, initiatives, and achievements of scientific and professional societies.
  • Scientific collaborations, multicenter research initiatives, and international academic partnerships.
  • Surgical education, professional training, simulation programs, and certification courses.
  • Developments in trauma systems, emergency care organization, and public-health preparedness.
  • Announcements of relevant scientific publications, research opportunities, and educational resources.
  • Academic appointments, professional recognitions, scientific awards, and institutional achievements.
  • Innovations in surgical practice, medical technologies, and healthcare delivery.
  • Journal announcements, editorial developments, special issues, and calls for papers.
  • Relevant public-health developments and professional initiatives affecting trauma and emergency surgical care.

Submissions must demonstrate clear relevance to the journal's scope and provide meaningful informational or educational value to its readership.

Scientific and Editorial Requirements

All News and Updates must be accurate, relevant, balanced, and supported by verifiable information.

Authors should clearly distinguish factual reporting from interpretation, institutional opinion, or promotional statements.

Whenever possible, information should be supported by official sources, published scientific literature, institutional communications, or other reliable documentation.

Reports describing clinical guidelines or scientific recommendations must accurately identify the issuing organization, publication date, and relevant source documents.

Conference and meeting reports should identify the event, organizing institution, dates, location, principal scientific themes, and relevant educational or professional outcomes.

Statements concerning clinical effectiveness, patient outcomes, or scientific advances must not exceed the available supporting evidence.

Promotional content, commercial advertising, unsupported scientific claims, and institutional publicity lacking professional or educational relevance are not suitable for this article category.

Submissions containing substantial original research data, detailed clinical investigations, or formal scientific analyses should be submitted under the appropriate research article category.

Manuscript Structure

News and Updates may follow a flexible narrative structure with appropriate thematic subheadings.

The recommended components are:

1. Title Page

The full article title, author names, institutional affiliations, corresponding author information, and required declarations, where applicable.

2. Introduction or Opening Statement

A concise description of the development, event, announcement, or professional activity being reported.

3. Main Content

A clear and logically organized presentation of the relevant information, including key developments, scientific or educational activities, institutional context, and supporting sources.

4. Scientific, Clinical, or Professional Relevance

A brief explanation of the significance of the reported development for clinical practice, scientific research, surgical education, patient safety, or healthcare organization, where appropriate.

5. Conclusions or Key Message

A concise summary of the principal information and its relevance to the journal's readership.

6. Declarations

Applicable statements regarding author contributions, conflicts of interest, funding, institutional affiliations, permissions, and other relevant disclosures.

7. References

Relevant scientific publications, official guidelines, institutional documents, or other verifiable sources, where necessary.

A conventional IMRaD structure and scientific abstract are not required.

Abstract Requirements

An abstract is not required for News and Updates.

Authors should begin the main text directly with the introduction or opening statement.

A brief editorial summary may be prepared for the journal's website or publication metadata when appropriate. Such a summary does not constitute a mandatory scientific abstract.

Reporting Guidelines

There is no universally mandated scientific reporting checklist specifically designed for conventional News and Updates.

Research reporting guidelines such as CONSORT, STROBE, STARD, CARE, and PRISMA are not routinely applicable to informational or professional news publications.

When a submission primarily reports original clinical research, a systematic review, or another formal study, it must be classified under the appropriate scientific article category.

A PRISMA checklist, PRISMA flow diagram, and research protocol registration are not required for conventional News and Updates.

Ethical Standards and Publication Integrity

All News and Updates must comply with AJTES policies on publication ethics, accuracy, transparency, authorship, conflicts of interest, confidentiality, copyright, and responsible scientific communication.

Authors must disclose relevant financial and non-financial interests, sponsorship, institutional affiliations, and other relationships that could influence the content.

When reporting activities supported by commercial sponsors, the nature of the sponsorship must be clearly disclosed. News and Updates must not be presented as independent scientific evidence when the content is primarily promotional.

Do not publish patient-identifying information, clinical photographs, or other confidential material without the necessary authorization and informed consent.

Photographs, logos, figures, and previously published materials must comply with applicable copyright, licensing, and permission requirements.

Where a report refers to another institution, society, or organization, the information must be accurate and should be appropriately attributed.

Editorial Assessment and Peer Review

All News and Updates undergo editorial assessment by the Editor-in-Chief or a designated member of the Editorial Board.

The assessment considers relevance, factual accuracy, reliability of sources, clarity, timeliness, professional significance, ethical compliance, and consistency with AJTES editorial policies.

External expert review or fact-checking may be requested when the content involves complex scientific claims, clinical recommendations, disputed information, or potentially consequential healthcare developments.

Routine external scientific peer review is not required for conventional News and Updates.

Publication is subject to editorial approval and does not imply endorsement by AJTES of any commercial product, organization, or institutional position.

Indexing and Publication Classification

News and Updates constitute editorial or informational content rather than primary original research.

Publication under this category does not guarantee indexing in Scopus, PubMed, MEDLINE, or other bibliographic databases.

Indexing eligibility and document classification depend on the policies, selection criteria, and content-type definitions of the relevant database.

AJTES will identify News and Updates accurately in its publication metadata and will not classify informational items as original research solely for indexing purposes.

 

Manuscript Requirements

 

Requirement

AJTES Standard

Article Type

News and Updates

Word Limit

Up to 1,500 words

Abstract

Not required

Abstract Model

Not applicable

Abstract Length

Not applicable

Abstract Headings

Not applicable

Keywords

Optional; 3–5

References

Up to 10

Tables and Figures

Up to 2 combined

Running Title

Required for journal articles; maximum 50 characters, excluding author prefix

Highlights

Optional

Manuscript Structure

Introduction or Opening Statement, Main Content, Professional Relevance, Conclusions or Key Message

Reporting Guideline

No specific research reporting guideline routinely required

Reporting Checklist

Not required

PRISMA Flow Diagram

Not applicable

PRISMA Checklist

Not applicable

Protocol Registration

Not required

Ethical Approval

Not ordinarily required for informational content; applicable requirements must be followed if identifiable patient information or original research is included

Informed Consent

Required where applicable, particularly for identifiable patient information or images

Conflict of Interest Statement

Required

Funding or Sponsorship Statement

Required

Author Contributions

Required for authored journal articles

Data Availability Statement

Not ordinarily applicable

Source Verification

Required for factual and scientific claims

Submission

Commissioned or editorially approved; unsolicited contributions may be considered

Peer Review

Editorial assessment; external review or expert verification when appropriate

Indexing Classification

Informational/editorial content; database indexing not guaranteed

Word-count policy: The word limit applies to the main manuscript text, excluding the title page, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to the prescribed word, reference, or figure limits may be considered when justified and approved by the responsible editor.

Congress Proceedings

Congress Proceedings (Conference Abstracts)

Definition and Scope

Congress Proceedings comprise collections of scientific abstracts accepted for presentation at national or international conferences, congresses, symposia, or scientific meetings organized, co-organized, or officially endorsed by the Albanian Society for Trauma and Emergency Surgery (ASTES) or other recognized scientific partners.

Accepted abstracts may be published as a dedicated supplement or special issue of the Albanian Journal of Trauma and Emergency Surgery (AJTES).

This publication category aims to facilitate the timely dissemination of scientific findings, clinical observations, emerging research, educational innovations, and professional developments relevant to trauma care, emergency surgery, acute care surgery, and related medical disciplines.

Congress Proceedings may include abstracts of original research, systematic reviews, clinical studies, case reports, case series, surgical innovations, and other scientifically relevant contributions accepted by the meeting's Scientific Committee.

Publication of a conference abstract represents dissemination of a scientific meeting contribution and must not be misrepresented as equivalent to publication of a complete, externally peer-reviewed research article.

Scientific and Editorial Requirements

Abstracts submitted for Congress Proceedings must be scientifically relevant, clearly written, accurate, and consistent with the objectives and scope of the scientific meeting.

Each abstract must provide sufficient information to enable readers to understand its scientific purpose, methodology or clinical context, principal findings, and conclusions.

Authors must ensure that:

  • The title accurately reflects the scientific content.
  • All authors and institutional affiliations are correctly identified.
  • The objectives are clearly stated.
  • The methodology or clinical approach is adequately described.
  • Principal results are reported accurately.
  • Conclusions are supported by the presented findings.
  • Relevant ethical and consent requirements have been satisfied.
  • Potential conflicts of interest and sources of funding are appropriately disclosed.
  • Previously published material is transparently acknowledged.

Abstracts containing unsupported conclusions, misleading scientific claims, inappropriate promotional content, or material that raises unresolved ethical concerns may be rejected or returned for correction.

Eligible Abstract Categories

Congress Proceedings may include the following types of contributions:

1. Original Research Abstracts

Brief reports of original clinical, observational, epidemiological, experimental, translational, or health-services research.

2. Systematic Review and Meta-Analysis Abstracts

Summaries of evidence syntheses conducted using appropriate systematic methodologies.

3. Case Report Abstracts

Concise descriptions of unusual, rare, or educationally significant clinical cases.

4. Case Series Abstracts

Summaries of multiple patients sharing relevant clinical conditions, interventions, or outcomes.

5. Surgical Innovation and Technical Abstracts

Reports of surgical techniques, procedural developments, clinical innovations, or technological applications.

6. Educational and Healthcare Systems Abstracts

Reports concerning surgical education, trauma systems, quality improvement, emergency preparedness, simulation, and professional training.

The Scientific Committee may establish additional submission categories according to the objectives of the meeting.

Abstract Structure

Abstracts should follow a structure appropriate to their scientific category.

A. Original Research Abstracts

A structured abstract is recommended using the following headings:

  • Background: Scientific context, rationale, and objective.
  • Methods: Study design, setting, population, interventions, and analytical methods.
  • Results: Principal findings, supported by relevant numerical data.
  • Conclusions: Main findings and their clinical or scientific implications.

B. Systematic Review Abstracts

Abstracts must summarize the review objective, information sources, eligibility criteria, synthesis methods, principal findings, and conclusions.

Authors should address the applicable PRISMA 2020 for Abstracts reporting items within the meeting's word limit.

C. Case Report Abstracts

Case Report abstracts may use an adapted structure:

  • Introduction or Background.
  • Case Presentation.
  • Discussion.
  • Conclusions or Clinical Learning Points.

D. Surgical, Technical, or Educational Abstracts

An adapted structure appropriate to the nature of the contribution may be accepted when approved by the Scientific Committee.

Abstracts must accurately represent completed findings. Preliminary research must be clearly identified as preliminary, and conclusions must be proportionate to the available evidence.

Manuscript and Abstract Submission Requirements

Each submitted abstract should include:

  1. Abstract Title: A concise, informative title reflecting the scientific contribution.
  2. Author Information: Full author names, affiliations, and corresponding author details.
  3. Abstract Text: Up to 350 words, using the appropriate format.
  4. Keywords: Three to six relevant terms, preferably aligned with Medical Subject Headings (MeSH).
  5. References: Up to five, when relevant and permitted by the meeting's submission rules.
  6. Tables and Figures: Up to one combined, when appropriate.
  7. Ethics and Consent Declarations: As applicable to the study or clinical material.
  8. Funding and Conflict-of-Interest Disclosures: As required by the meeting and journal.
  9. Registration Information: For clinical trials or other research requiring registration.
  10. Originality and Publication Declaration: Disclosure of prior presentation, publication, or related submissions.

The Scientific Committee may establish supplementary requirements or submission templates for individual meetings.

Scientific Selection and Editorial Assessment

Scientific abstracts are evaluated and selected for presentation by the meeting's Scientific Committee according to the congress's established scientific criteria.

Following scientific acceptance, abstracts intended for publication undergo editorial screening by AJTES to assess:

  • Relevance to the journal's scope.
  • Completeness of essential bibliographic information.
  • Scientific clarity and consistency.
  • Accuracy of titles, authorship, and affiliations.
  • Compliance with ethical and publication requirements.
  • Appropriate disclosure of conflicts of interest and funding.
  • Suitability for publication in the designated supplement.

Congress abstracts are not routinely subjected to the same external double-anonymized peer-review process applied to full-length Original Research Articles.

The published supplement must clearly disclose the actual scientific selection, editorial assessment, and peer-review procedures used.

The Editor-in-Chief retains final responsibility for journal publication decisions and may require revisions, seek additional expert assessment, or decline publication of individual abstracts.

Publication Format and Supplement Identification

Congress Proceedings are published as identifiable AJTES supplements or special issues under the journal's registered ISSN, subject to the journal's publication policies.

Each supplement must include:

  • The official title of the scientific meeting.
  • The name of the organizing scientific society or institution.
  • The location and dates of the meeting.
  • The journal title and ISSN.
  • Volume, issue or supplement designation, and publication date.
  • Editorial and Scientific Committee information, where appropriate.
  • A statement describing abstract selection and editorial review.
  • Sponsorship and funding disclosures, including a statement when no external sponsorship was received.
  • Complete and accurate bibliographic metadata.
  • DOI information, where assigned.

A DOI may be assigned to the supplement as a whole and, when appropriate, to individual abstracts according to AJTES publishing and DOI registration policies.

Each assigned DOI must resolve to a stable publication record containing accurate bibliographic metadata.

Individual abstract DOIs are not mandatory solely because the supplement has a DOI.

Relationship to Subsequent Full-Length Publication

Publication of a preliminary scientific abstract in Congress Proceedings does not ordinarily preclude subsequent consideration of a complete research manuscript by AJTES or another scientific journal.

This approach is consistent with internationally recognized publication ethics recommendations concerning preliminary reports presented at scientific meetings.

Authors submitting a full-length manuscript based on a previously published congress abstract must:

  • Clearly disclose the prior abstract publication in the cover letter or submission declaration.
  • Provide the title, meeting name, publication details, and DOI or persistent link, where available.
  • Cite the previously published abstract when relevant and bibliographically appropriate.
  • Ensure that the full manuscript provides a complete and scientifically substantive account of the research.
  • Transparently identify any relevant differences between the preliminary abstract and the final report.
  • Avoid duplicate publication, inappropriate reuse of published material, or misleading representation of originality.

Subsequent full-length manuscripts submitted to AJTES must undergo the normal editorial and external peer-review process required for the relevant article category.

Publication of the conference abstract does not guarantee acceptance of the full manuscript.

When technically supported, AJTES should establish a bibliographic relationship between the published abstract and the subsequent full article.

Ethical Approval, Patient Consent, and Confidentiality

All abstracts must comply with applicable institutional, national, and international research ethics standards.

Research involving human participants, biological materials, or identifiable health data must report the relevant ethics committee approval, exemption, or authorized waiver, where applicable.

Where approval was granted, the responsible committee and approval identifier should be provided in the submission documentation.

Authors must confirm that the informed consent requirements applicable to their study design have been satisfied or appropriately waived.

Identifiable patient information, clinical photographs, and other potentially identifying material must not be published without appropriate authorization and informed consent for publication.

All direct and indirect patient identifiers must be removed unless their inclusion is essential, justified, and appropriately authorized.

Clinical trials must comply with applicable prospective trial registration requirements.

Ethical approval, informed consent for research participation, and consent for publication are distinct requirements and must be addressed accordingly.

Reporting Guidelines

Abstracts should follow the reporting principles appropriate to the underlying scientific study design.

Applicable frameworks may include:

  • CONSORT for Abstracts: Randomized controlled trials.
  • STROBE: Relevant principles for observational research.
  • PRISMA 2020 for Abstracts: Systematic reviews and meta-analyses.
  • CARE: Relevant elements for individual case reports.
  • PROCESS: Relevant elements for surgical case series.
  • STARD: Relevant principles for diagnostic accuracy studies.

The full reporting checklist is not routinely required for every conference abstract.

A full PRISMA flow diagram is not ordinarily required for an abstract-only proceedings publication. However, abstracts reporting systematic reviews should provide sufficient study-selection and synthesis information to satisfy applicable PRISMA for Abstracts requirements within the available format.

Full reporting checklists and additional methodological documentation may be requested when necessary.

Protocol and Trial Registration

Protocol registration is not ordinarily required for all conference abstracts.

Clinical trials must comply with applicable prospective registration requirements regardless of whether their findings are initially presented as a congress abstract.

For systematic reviews, prospective protocol registration is strongly recommended where eligible, and available registration information should be reported.

For other study designs, registration or public availability of a study protocol is encouraged where appropriate.

Sponsorship, Editorial Independence, and Research Integrity

All Congress Proceedings must comply with AJTES policies on editorial independence, publication ethics, authorship, conflicts of interest, sponsorship, and scientific integrity.

The supplement must clearly disclose the organizations responsible for the scientific meeting and any financial or institutional support provided for its organization or publication.

Editorial decisions regarding publication must remain under the responsibility of AJTES.

Financial sponsors, commercial partners, or meeting organizers must not control the journal's final editorial decisions.

Any relevant relationships between authors, supplement editors, scientific organizers, and sponsoring organizations must be disclosed in accordance with applicable journal policies.

The supplement must clearly distinguish conference abstract selection from external peer review of full scientific manuscripts.

Indexing and Bibliographic Classification

Publication in an AJTES supplement does not automatically guarantee inclusion or individual abstract indexing in Scopus, PubMed, MEDLINE, or other bibliographic databases.

Indexing eligibility depends on the policies, content selection criteria, publication-type classifications, and technical requirements of the relevant database.

AJTES must accurately identify Congress Proceedings as conference abstract collections and must not represent abstracts as full-length peer-reviewed research articles.

Manuscript Requirements

 

Requirement

AJTES Standard

Article Type

Congress Proceedings (Conference Abstracts)

Word Limit

Up to 350 words per abstract

Abstract

The publication itself is an abstract

Abstract Model

Structured for original research; adapted for other contribution types

Abstract Headings

Background, Methods, Results, Conclusions; alternatives as appropriate

Keywords

3–6, recommended

References

Up to 5

Tables and Figures

Up to 1 combined

Running Title

Not required for individual abstracts

Highlights

Not required

Manuscript Structure

Title, Authors/Affiliations, Abstract, Keywords, Applicable Declarations

Reporting Guideline

According to study design; abbreviated conference-abstract reporting

Reporting Checklist

Not routinely required; may be requested

PRISMA Flow Diagram

Not routinely required for abstract-only proceedings

PRISMA Checklist

Relevant PRISMA for Abstracts items for systematic review abstracts

Protocol Registration

Required for applicable clinical trials; otherwise according to research design

Ethical Approval

Required where applicable; documented exemptions or waivers accepted

Informed Consent

According to applicable study requirements

Consent for Publication

Required for identifiable patient information

Conflict of Interest Statement

Required

Funding / Sponsorship Disclosure

Required

Originality Declaration

Required

Scientific Committee Selection

Required

AJTES Editorial Screening

Required

External Peer Review

Not routinely performed

Publication Format

Identifiable journal supplement or special issue

Supplement DOI

According to AJTES DOI registration policy

Individual Abstract DOI

Optional

Subsequent Full Publication

Permitted subject to transparent disclosure and normal peer review

Indexing

Not guaranteed

 

Word-count policy: The 350-word limit applies to the abstract text and excludes the title, author list, affiliations, references, and any permitted table or figure legend.

Editorial discretion: The Scientific Committee and AJTES Editorial Office may establish additional requirements or approve justified exceptions according to the scientific meeting and publication format.

Conference Paper

Definition and Scope

Conference Papers are full-length scholarly manuscripts developed from research or scientific work previously presented at a recognized national or international congress, conference, symposium, or scientific meeting.

These manuscripts provide a complete, methodologically sound, and scientifically rigorous account of the underlying research and are submitted for publication in a regular issue of the Albanian Journal of Trauma and Emergency Surgery (AJTES).

Unlike Conference Abstracts published in Congress Proceedings, Conference Papers constitute full-length scientific publications and must meet the same standards of originality, methodological transparency, ethical compliance, scientific reporting, and peer review as the corresponding Original Research Article, Review Article, or other appropriate article category.

Conference presentation or prior publication of a preliminary abstract does not automatically preclude submission of a complete manuscript.

However, all previous presentations, abstracts, proceedings publications, preprints, and substantially related manuscripts must be transparently disclosed at submission.

Eligible Contributions

Conference Papers may include:

  • Original clinical, observational, epidemiological, or experimental research.
  • Randomized controlled trials and other interventional investigations.
  • Prospective and retrospective clinical studies.
  • Diagnostic accuracy and outcomes research.
  • Systematic Reviews and Meta-Analyses.
  • Narrative Reviews developed from scientific conference presentations.
  • Translational and laboratory-based research.
  • Surgical innovation and technical research.
  • Healthcare quality improvement and health-services research.
  • Research concerning trauma systems, emergency preparedness, and surgical education.

The final manuscript must be categorized and evaluated according to its underlying scientific methodology.

Scientific and Methodological Requirements

Conference Papers must provide a complete and scientifically coherent presentation of the research undertaken.

The manuscript must include:

  • A clearly defined research question or objective.
  • Relevant scientific background and rationale.
  • Appropriate and transparent methodology.
  • Adequate description of the study population or research material.
  • Clearly defined outcome measures, where applicable.
  • Appropriate statistical or qualitative analyses.
  • Complete presentation of relevant results.
  • Critical interpretation of findings.
  • Methodological limitations and potential sources of bias.
  • Conclusions directly supported by the evidence.

Authors must not omit essential methodological information or selectively report findings solely because the research was previously presented at a scientific meeting.

The scientific quality and completeness of the manuscript must be equivalent to the standards required for a full-length article of the corresponding category.

Manuscript Structure

Conference Papers must follow the structure required for the underlying article type.

1. Title Page

A separate title page containing the full manuscript title, author names, institutional affiliations, corresponding author information, and required declarations.

2. Abstract

A structured or unstructured abstract, according to the underlying article category.

For Original Research Articles, the structured abstract should include Background, Objective, Methods, Results, and Conclusions.

3. Keywords

Three to six relevant keywords, preferably aligned with Medical Subject Headings (MeSH).

4. Introduction

Scientific background, relevant literature, knowledge gap, and the research objective or hypothesis.

5. Materials and Methods

For original research, a complete description of the study design, setting, participants, methods, outcome measures, statistical analyses, and ethical considerations.

For review articles, the methods and structure must comply with the relevant review category.

6. Results

A complete and accurate presentation of the principal findings, supported by appropriate numerical data, tables, and figures, where applicable.

7. Discussion

Critical interpretation of the findings in relation to existing evidence, including clinical significance, methodological strengths, limitations, and implications for future research.

8. Conclusions

Evidence-based conclusions directly addressing the research objectives.

9. Previous Conference Presentation Statement

A declaration identifying the scientific meeting at which the work was previously presented.

10. Declarations

Ethical approval, informed consent, clinical trial registration where applicable, author contributions, conflicts of interest, funding, data availability, and other required statements.

11. References

Relevant scientific references, including the previously published conference abstract or related publication where applicable.

12. Supplementary Materials

Reporting checklists, protocols, additional analyses, supplementary tables, and other relevant supporting documentation, where appropriate.

Previous Conference Presentation and Abstract Disclosure

Authors must disclose any previous scientific presentation or preliminary publication of the work.

The submission must identify:

  • The official title of the conference or scientific meeting.
  • The organizing institution or scientific society.
  • The date and location of the meeting.
  • The format of presentation, such as oral presentation, poster, or invited scientific communication.
  • Whether a conference abstract was formally published.
  • The bibliographic details and DOI of any published abstract, where available.

A published conference abstract must be appropriately cited when relevant and bibliographically identifiable.

Authors must disclose related manuscripts, proceedings papers, preprints, or other publications that substantially overlap with the submitted work.

Copies or links to relevant earlier publications must be provided to the Editorial Office when requested.

Relationship to Prior Abstracts and Full Publications

Presentation of research at a scientific meeting, including publication of a preliminary conference abstract, does not automatically constitute prior full publication.

AJTES may consider a complete manuscript developed from a previously presented abstract, provided that:

  • The prior presentation and abstract publication are fully disclosed.
  • The submitted manuscript meets the requirements of the appropriate full-length article category.
  • The manuscript provides a scientifically complete account of the research.
  • The published abstract is cited where appropriate.
  • The submission does not constitute undisclosed duplicate publication.

Once published as a full-length Conference Paper, the article is considered a complete scholarly publication.

Subsequent publication of substantially overlapping content without transparent disclosure and appropriate justification is not permitted.

Authors developing further research from a previously published Conference Paper must submit a scientifically distinct manuscript that offers a substantial additional contribution, such as new data, a separate research question, materially extended follow-up, or new analyses addressing a genuinely different objective.

Any subsequent manuscript must clearly cite and disclose the earlier publication. The Editorial Office will assess whether the new contribution is sufficiently distinct to warrant consideration.

Routine expansion, rewriting, or repackaging of a previously published paper without substantial scientific novelty is not acceptable.

Research Reporting Guidelines

Conference Papers must comply with the reporting guideline appropriate to their underlying study design.

Applicable guidelines include:

  • CONSORT 2025: Randomized controlled trials.
  • STROBE: Cohort, case-control, and cross-sectional studies.
  • STARD: Diagnostic accuracy studies.
  • PRISMA 2020: Systematic Reviews and Meta-Analyses.
  • CARE: Case Reports.
  • PROCESS: Surgical Case Series.
  • ARRIVE 2.0: Animal research.
  • TRIPOD / TRIPOD+AI: Clinical prediction model studies.
  • SQUIRE 2.0: Healthcare quality improvement studies, where applicable.

Authors must submit the relevant reporting checklist when required by the underlying study design and AJTES submission policy.

A PRISMA checklist and PRISMA flow diagram are mandatory only when the manuscript reports a Systematic Review or Meta-Analysis.

Protocol Registration

Protocol or trial registration requirements depend on the underlying research design.

Clinical trials meeting the applicable ICMJE definition must comply with prospective registration requirements.

The registry name, registration number, and relevant registration information must be reported.

For eligible systematic reviews, prospective protocol registration is strongly recommended. Authors must report the registration details or explain the absence of registration, in accordance with AJTES policy.

For observational or other non-trial investigations, registration is encouraged where appropriate but is not ordinarily mandatory unless required by applicable regulations, funding conditions, or journal policy.

Previous presentation at a scientific conference does not exempt the study from applicable registration requirements.

Ethical Approval and Informed Consent

All Conference Papers must comply with applicable national and international research ethics requirements.

Research involving human participants, human biological materials, or identifiable health information must report the applicable ethical review and approval, exemption, or authorized waiver.

The manuscript must identify the responsible ethics committee or institutional review board and provide the approval number and date, where applicable.

Authors must address the informed consent requirements relevant to the research design.

Any authorized waiver of informed consent must be documented.

Identifiable patient information or clinical images must not be published without the required consent and authorization.

Research involving animals must comply with applicable institutional and national animal welfare requirements.

Authorship, Funding, and Research Integrity

All Conference Papers must comply with AJTES policies on authorship, originality, research integrity, conflicts of interest, funding disclosure, data transparency, and responsible use of artificial intelligence.

The authorship of the full manuscript must accurately reflect the contributions made to the submitted work.

Any differences between the authorship of the earlier conference abstract and the full manuscript should be explained when relevant to authorship integrity.

Financial support, conference sponsorship, industry involvement, and other relationships that may influence the research must be disclosed.

Previously published abstracts, figures, tables, or text must be appropriately cited, and copyright or licensing requirements must be respected.

Submission Requirements

Authors must use the official AJTES manuscript templates and provide the required supporting documents:

  1. AJTES – Anonymised Manuscript Template.
  2. AJTES – Author Declaration Form.
  3. AJTES – Cover Letter Template.
  4. AJTES – Title Page Template.

The Cover Letter must clearly disclose the previous conference presentation and any published abstract or related publication.

The submission must also include the relevant reporting checklist, registration information, and ethical declarations where applicable.

Incomplete submissions may be returned to the corresponding author for correction before editorial assessment or external peer review.

Editorial Assessment and Peer Review

Conference Papers undergo preliminary editorial screening to assess scientific relevance, originality, methodological completeness, ethical compliance, and adherence to AJTES requirements.

Manuscripts considered suitable undergo external double-anonymized peer review, ordinarily involving at least two independent reviewers.

Additional methodological or statistical review may be requested where appropriate.

Acceptance for presentation at a scientific conference does not guarantee acceptance for publication in AJTES.

The final editorial decision rests with the responsible editor and is based on scientific quality, methodological validity, reviewer recommendations, and compliance with the journal's editorial policies.

Manuscript Requirements

Requirement

AJTES Standard

Article Type

Conference Paper (Full-Length Manuscript)

Word Limit

According to underlying article type

Abstract

Required according to underlying article type

Abstract Model

Structured or unstructured, as applicable

Abstract Headings

According to underlying article type

Keywords

3–6, preferably MeSH-aligned

References

According to underlying article type

Tables and Figures

According to underlying article type

Running Title

Required; maximum 50 characters, excluding author prefix

Highlights

3–5, maximum 85 characters each, for research articles and reviews

Manuscript Structure

Corresponding full-length research or review structure

Reporting Guideline

According to study design

Reporting Checklist

Required where applicable

PRISMA Flow Diagram

Required for systematic reviews only

PRISMA Checklist

Required for systematic reviews only

Protocol Registration

According to underlying study design

Previous Conference Disclosure

Required

Previous Abstract Citation

Required when applicable

Originality and Overlap Declaration

Required

Ethical Approval

Required where applicable; authorized exemptions or waivers accepted

Informed Consent

Required where applicable

Author Contributions

Required

Conflict of Interest Statement

Required

Funding Statement

Required

Data Availability Statement

Required where applicable

Submission Documents

Four official AJTES submission templates

Peer Review

Double-anonymized external peer review, ordinarily by at least two independent reviewers

Publication Format

Full-length article in a regular issue

DOI

Separate DOI assigned upon publication

Subsequent Expanded Publication

Considered only when scientifically distinct, transparently disclosed, and appropriately cited

Word-count policy: The main-text word limit follows the corresponding article category and excludes the title page, abstract, references, tables, figure legends, and supplementary materials.

Editorial discretion: Exceptions to the prescribed limits may be considered when scientifically justified and approved by the Editorial Office.

Copyright Notice

Copyright for all articles published in AJTES is retained by the author(s). By publishing in the journal, authors grant AJTES a non-exclusive, worldwide, perpetual licence to publish, reproduce, distribute, archive, and preserve the article as the Version of Record, to deposit its metadata with Crossref and indexing services, and to be identified as its original publisher. The journal acquires no rights in a manuscript that is rejected or withdrawn before acceptance.

Articles published from 1 November 2026 are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Third parties may copy, redistribute, and adapt the published work for any purpose, including commercially, provided that appropriate credit is given to the original author(s) and source, a link to the licence is provided, and any changes are indicated. Articles published before 1 November 2026 keep the licence they were published under, shown on each article’s page: CC BY-NC 4.0, or CC BY-NC-ND 4.0 for Volume 10, Issue 2 (2026).

Authors who are legally prevented from retaining copyright (for example, government employees or Crown copyright holders) must notify the Editorial Office at submission so that an appropriate copyright statement can be applied. Copyright and licensing terms cannot be changed after publication, because the published article is the definitive Version of Record.

By submitting, the corresponding author warrants on behalf of all authors that the work is original, that the authors have the right to grant this licence, and that written permission has been obtained for any third-party material reproduced in the article.

The copyright holder and the licence are stated on each article’s landing page and on the first page of the article PDF, together with a link to the licence deed. AJTES does not require or accept a transfer of copyright, and no agreement offered by the journal asks authors to assign copyright to the journal or to the publisher. Where any earlier AJTES document or form states otherwise, this notice prevails.

The declarations and licence terms the corresponding author accepts at submission, by signing Part E of the Author Declaration Form (effective only on acceptance), are set out in the Author Licence to Publish Agreement.

Version 1.1, approved by the Editorial Board on 30 July 2026. Reviewed at least every two years.

Privacy Statement

The Albanian Journal of Trauma and Emergency Surgery (AJTES) is committed to protecting the privacy of everyone who uses this website — authors, reviewers, editors, and readers. This statement explains what personal data we collect, why we collect it, how it is handled, and what rights you have.

Data controller. The Albanian Society for Trauma and Emergency Surgery (ASTES), publisher of AJTES, Street “Lord Bajron” No. 40, 1000 Tirana, Albania. Enquiries about this statement or about your personal data should be sent to the Editorial Office at editorial@journal.astes.org.al.

What we collect and why

The names and email addresses entered on this site are used only for the purposes described below. They are never sold or rented, and are not released for marketing.

  • Account information — name, affiliation, email address, country, and ORCID iD where provided. Collected when you register, so that we can operate the editorial process and correspond with you.
  • Submission data — manuscripts and supplementary files, co-author names and contact details, the corresponding author’s postal address and telephone number, and all editorial correspondence. Used to manage peer review, editorial decisions, and publication.
  • Ethics documentation — ethics committee approvals and consent forms uploaded by authors. These are seen only by editorial staff, are never published, and may contain third-party information; authors must redact patient-identifying details before uploading.
  • Reviewer data — areas of expertise, review history, and the reviews themselves, kept so that we can invite reviewers appropriately and acknowledge their work.
  • Technical data — server logs and aggregate usage statistics, used to keep the site secure and to report article-level usage.

Applicable law and legal basis

This statement is given effect under Albanian Law No. 124/2024 on the Protection of Personal Data, which entered into force in February 2025 and repealed Law No. 9887 of 10 March 2008, and — in respect of data subjects in the European Economic Area — under the General Data Protection Regulation (EU) 2016/679, with which the Albanian law is harmonised.

Personal data is processed on the following bases:

  • Contract and pre-contractual steps (GDPR Art. 6(1)(b)) — managing your submission, review assignment, or account.
  • Legitimate interests (GDPR Art. 6(1)(f)) — the legitimate interests of a scholarly publisher in operating peer review, maintaining the integrity of the published record, and securing the site. We have assessed that these interests are not overridden by your rights, because the data involved is professional rather than sensitive and its use is what a person submitting or reviewing scholarly work would reasonably expect.
  • Consent (GDPR Art. 6(1)(a)) — announcements and other optional communications. You may withdraw consent at any time without affecting the lawfulness of earlier processing.
  • Legal obligation (GDPR Art. 6(1)(c)) — where retention or disclosure is required by law.

Processors and hosting

The journal’s website and editorial system are hosted by a commercial web hosting provider, and transactional email is delivered through a third-party email service. These suppliers act as data processors on the journal’s instructions, are bound by contract to process personal data only as instructed and to apply appropriate security measures, and do not use the data for their own purposes.

How your data is used

Data is used only to run the journal: managing submissions and peer review, communicating decisions, publishing accepted articles, and maintaining the published record. Author names, affiliations, and ORCID iDs in published articles become part of the permanent public record of the work, in line with standard scholarly practice.

Sharing and third parties

Limited data is shared only where it is essential to publication: article and author metadata is registered with Crossref for DOI assignment, and published metadata is harvested by indexing and discovery services such as DOAJ and Google Scholar. Peer review is double-anonymised: author and reviewer identities are not disclosed to one another. We do not transfer personal data to any other third party except where required by law.

Retention

Published article data is retained permanently as part of the scholarly record. Editorial records for submissions that were rejected or withdrawn are retained for five years, after which they are deleted. Inactive user accounts that have never been used to submit or review may be removed after three years.

Your rights

You have the right to access your personal data, to have inaccurate data corrected, to request erasure, to restrict or object to processing, and to receive your data in a portable form. Exercise any of these rights by writing to the Editorial Office; we respond within 30 days. If you are not satisfied with our response, you may complain to the Albanian Information and Data Protection Commissioner (idp.al), or, if you are in the European Economic Area, to your national supervisory authority. Note that information forming part of a published article — authorship, affiliation, and the content of the Version of Record — cannot be removed, as it is part of the permanent scholarly record; corrections to the record are made through published corrections.

Cookies

This site sets only the cookies necessary for the platform to function — principally a session cookie to keep you signed in, and a cookie recording your language preference. No advertising, profiling, or third-party tracking cookies are used.

Contact

Questions about this privacy statement, or about how your data is handled, should be addressed to the AJTES Editorial Office, Street “Lord Bajron” No. 40, 1000 Tirana, Albania — editorial@journal.astes.org.al.

Version 1.1, approved by the Editorial Board on 30 July 2026. Reviewed at least every two years.

Ready to submit?

Submissions go through full peer review, and accepted articles are published open access so anyone can read them.

Submit a manuscript